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Abstract 
Purpose:  Cancer-related cognitive impairment (CRCI) has been associated with 
fatigue, emotional distress, reduced quality of life, and caregiver strain.  A potential 
treatment option for those with CRCI is cognitive rehabilitation, a behavioural 
approach to improve cognitive skills and quality of life.  There have been some 
studies that involve caregivers in aspects of rehabilitation.  There are no studies in the 
literature however, that include direct retraining of survivors on lost functions and 
concurrent participation by their caregivers across all sessions.  To fill this gap, a 
comprehensive 10-week cognitive rehabilitation program (CRP) was created, with 
aims to generalize improvement to everyday life in survivors of breast cancer.   
Methods:  A manualized CRP was developed and piloted with breast cancer survivors 
(BCSs) and their training partners.  The program focused on psychoeducation and 
direct training on communication strategies, breathing/relaxation techniques, simple 
and complex attention, and higher-order thinking.  Outcome measures included 
feasibility (retention and attendance rates), acceptability (homework compliance, 
session and program satisfaction), and measures of cognitive functioning and quality 
of life.  BCSs and their individual partner underwent assessments at baseline, 
immediately after completing the program, and approximately 10 weeks later in order 
to investigate maintenance effects.   
Results:  Six BCSs (ages 44-59; ≥1 year post-chemotherapy) and their training 
partners enrolled and completed this study with a (100% retention rate).  Rates of 
attendance were high for both BCSs and their training partners (94% and 92.5% 
respectively) with all participants indicating high levels of satisfaction with the 
 iv 
program.  Repeated measures analyses of variance (ANOVAs) did not reveal a 
significant main effect for time on measures of sustained attention, processing speed, 
executive function, fluency (semantic and phonemic), verbal and visuospatial 
learning, recall and recognition.  Repeated measures ANOVA revealed a significant 
main effect for time on measures of attentional capacity, focused attention, motor 
dexterity with the non-dominant hand, confrontation naming, and overall quality of 
life.  Additionally, analyses using adjusted reliable change indices (RCI) were 
conducted on individual cases.  RCIs yielded no change on most measures across 
time.  
Conclusions:  Findings suggest that a group-based CRP using a concurrent BCS 
/training partner approach was feasible, acceptable and proved beneficial to its 
participants.  There were no significant main effects on most neuropsychological 
measures.  Trends towards improvement on most measures across time seem to 
warrant further investigation, despite the small sample size and lack of statistical 
significance.  The findings support a need to refine the intervention and to assess 
therapeutic efficacy with a planned randomized control trial.   
 
Keywords 
Breast cancer, cognition, rehabilitation, cancer-related cognitive impairment, 
neuropsychology, feasibility, pilot study
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Chapter 1: Introduction/Problem Statement 
In recent years, cognitive functioning in individuals with cancer has been 
recognized as an important oncological outcome similar to survival and time to disease 
progression.  Cancer-related cognitive impairment (CRCI) has emerged as a key focus of 
cancer survivorship research, with special focus on individuals with breast cancer.  In 
conjunction, approximately 30% of breast cancer survivors (BCSs) report cognitive 
impairment.  These cognitive deficits result in adverse impacts on the survivor’s ability to 
complete activities of daily living and subsequently on their quality of life.  Although 
programs geared at reversing cognitive decline in this population seem crucial, there is a 
paucity of research in this area, especially with respect to efficacy of rehabilitation 
protocols.  The limited research conducted on this topic has focused on direct individual 
retraining rather than implementation of a concurrent individual and training partner (e.g. 
spouse, sibling, close friend) program that aims to generalize gains to the individual’s 
everyday life.  Caregivers are often used as proxy informants to report an individual’s 
cognitive deficits and quality of life.  There has been little consideration in the literature 
regarding the potential positive effects and therapeutic opportunities that may be derived 
from working simultaneously with the survivor and caregiver (the training partner).  The 
purpose of this pilot study was to evaluate the feasibility and acceptability of a 10-week 
neuropsychological rehabilitation program designed for BCSs and their partners.  The 
aims were to improve attention, problem-solving ability, planning and organization skills, 
self-efficacy, quality of life and communication in BCSs.  Each BCS and their training 
partner partook in the rehabilitation program.  The survivors underwent a baseline 
neurocognitive assessment (Time 0) as well as follow-up assessments at approximately 
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10 (Time 1) and approximately 20 (Time 2) weeks post-intervention to assess treatment 
effects, spontaneous recovery, and maintenance of effects over time.  
A gap exists in the literature as how to best manage CRCI in BCSs and caregivers 
concurrently using a rehabilitation approach.  The results of this pilot study may fill this 
gap by offering a CRP using direct retraining and compensatory strategies.  One of the 
advantages of the CRP intervention is that it is manualized; therefore it is reproducible 
and may be adapted to various disease sites, and/or implemented in other cancer centres 
to rehabilitate cognitive deficits resultant from cancer treatment.  Given the increasing 
prevalence of CRCI in BCSs, it is imperative that health care providers better equip 
themselves with the knowledge and skill to help BCSs and caregivers incorporate 
positive attitudes, thoughts, and beliefs about CRCI into behavioural changes that could 
improve aspects of attention and executive functioning.  
 
Rationale for the Project 
A number of published studies demonstrated the benefits of rehabilitation in 
individuals with traumatic brain injury who encounter cognitive challenges similar to 
those of BCSs (Cicerone et al., 2005; Cicerone et al., 2008).  The cognitive deficits 
observed in BCSs are mild but nonetheless impact the survivors’ activities of daily living, 
and subsequently, subjective quality of life (Kohli et al., 2009).   
Although memory deficits are observed in the breast cancer population, the 
pattern of test results typically involves inefficient learning and retrieval rather than a 
primary memory deficit such as encoding and forgetfulness.  Reid-Arndt et al. (2009) 
reported that executive functioning deficits were associated with declines in functional 
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outcomes, reduced engagement in social and community activities, and greater 
difficulties functioning effectively in important social roles such as spouse, parent, or 
employee among BCSs.  They concluded that treatment efforts focusing to address 
cognitive, psychological, and physical issues show promise among cancer survivors.  
Improving executive abilities may help survivors across other functional domains.  A 
need exists for rehabilitation programs that retrain, restore and/or remediate deficits in 
executive function and subsequently use these skills more effectively in servicing other 
cognitive functions.  By extension, a rehabilitation program designed to address these 
executive deficits could result in improved everyday functioning in BCSs.  The pilot 
program is designed to be a comprehensive model for treating BCSs who have 
objectively identified cognitive impairments following cancer treatment.  While it may 
appear that the program is aimed at those with cognitive impairment, there can be a 
number of survivors with more extensive cognitive issues that could benefit from the 
cognitive rehabilitation program (CRP) as well.   
 Despite the importance of cognitive rehabilitation, currently there are no studies 
of cognitive rehabilitation in individuals with cancer that are designed with collateral 
partner or caregiver participation.  Furthermore, Mosher et al. (2013) reported that family 
caregivers of cancer patients also suffered distress throughout the patient's journey of 
cancer treatment.  The authors found that more than 50% of family caregivers reported 
reductions in time for social activities, low levels of energy, poor emotional well-being 
and an inability to cope with stress (Mosher et al., 2013).  The least reported effects were 
on the caregivers’ self-esteem, and relationships with patients and other family members.  
Interestingly, approximately 40% of caregivers, reported positive changes, in their 
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relationships with the patients and other family members as result of caregiving.  
Caregiver’s mental health was strongly associated with life changes and more so than 
physical health (Mosher et al., 2013).  Sherwood and colleagues (2008) propose that 
caregiver psychological health outcomes (defined as emotional distress, depressive 
symptoms, and anxious symptoms) are affected by both disease characteristics (e.g., 
disease stage, time since diagnosis, functioning and needs) and caregiver personal 
characteristics and resources (e.g., socio-demographic factors and social support).  
Caregivers are often involved in the rehabilitation of the deficits observed in their loved 
one with cancer.  There has been little consideration in the literature concerning potential 
positive effects and therapeutic opportunities from working simultaneously with a 
survivor and caregiver.  The few intervention studies conducted on this topic have done 
so with direct patient retraining.  Implementation was not assessed on a concurrent 
program addressing the needs of both the affected individuals and their caregivers.  
Direct retraining is expected to help generalize strategies to the individual’s everyday 
life.  
 Sohlberg and Mateer (2001) outlined three different phases of involvement in 
rehabilitation activities for families that were adapted for this study: 1) interviewing; 2) 
identifying and prioritizing goals; and 3) monitoring changes and revisiting goals.  
Caregivers can provide perspective around day-to-day difficulties experienced by the 
client, benefit from access to information, while helping to identify and work towards the 
goals of therapy.   
 An intervention aimed at improvement for BCSs with cognitive deficits has the 
potential to reduce everyday problems created by attention and memory lapses, reduce 
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secondary problems such as stress and/or fatigue, and improve well-being both for the 
caregiver and the survivor.  An effective intervention with a training partner should help 
address the negative aspects of survivor-caregiver interactions and assist the training 
partner with empathizing with deficits of the survivors.  For the training partners, these 
sessions should help identify, understand, normalize, and additionally help compensate 
for their partners breast-cancer-induced deficits.  The proposed CRP aims to directly and 
indirectly address these issues.  This pilot CRP is the suspected first use of a survivor-
partner dyad beyond one session using this particular interventional format.  This study is 
aimed at piloting the CRP in order to determine if the survivor-partner dyad 
interventional strategy could affect improvements to the functioning in the survivor’s 
everyday life.  These strategies include direct retraining of survivors on lost functions and 
concurrent participation by their caregivers across all sessions.  To address this gap, a 
comprehensive 10-week cognitive rehabilitation pilot program (CRP) was created, with 
aims to generalize improvement to everyday life in survivors of breast cancer.   
 
Aims and Research Hypotheses 
The primary aim of this pilot study was to determine the feasibility and 
acceptability of a CRP to BCSs and their training partners.  For this study, feasibility was 
defined by the ability to implement and complete a 10-week CRP.  Feasibility was 
assessed by recruitment strategies, attrition rate, and attendance rates.  Feasibility 
parameters would be accomplished by achieving the following targets: 
1. Recruitment of 10 survivor-partner dyads within a 4- month recruitment 
period.  
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2. A minimum weekly attendance rate of 75% for all participants.  
3. Retention of greater than 75% of participants at the end of the program.  
The construct of treatment acceptability as defined by Kazdin (1980) involves the 
perceived appropriateness of treatment by potential clients or the degree to which 
individuals perceive a treatment to be appropriate, fair and reasonable (Kazdin, 1981, p. 
493).  For this study, acceptability was defined by the ease to which the participants used 
the CRP and how the participants felt the program fit their needs.  Acceptability was 
assessed by homework compliance, responses from weekly session questionnaires and a 
final program satisfaction questionnaire administered to participants.  The secondary aim 
of this study was to determine if the CRP resulted in improvement on objective and 
subjective neuropsychological outcomes.  As the first pilot study in this area, it presented 
a unique opportunity to help guide procedures to implement a randomized control trial 
and/or larger, multi-centre trials in the future.   
The proposed study addressed three primary hypotheses related to the possibility 
that short-term cognitive rehabilitation will result in: 
1. measurable improvements in neuropsychological performance. 
2. sustained improvements over time demonstrated through objective 
measurements. 
3. concomitant with hypotheses 1 and 2, observable gains in the performance of 
activities of daily living.  
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Chapter 2: Literature Review 
Cancer patients and survivors have reported numerous adverse symptoms 
associated with their disease and treatment including cognitive dysfunction, fatigue and 
affective distress.  In particular, cognitive dysfunction has emerged as one of the most 
puzzling and concerning adverse effects in this population.  The incidence of cognitive 
impairment varies by type of cancer, type of treatment, and time elapsed since diagnosis 
(Allen, 2011).  Dietrich (2012) reported incidences ranging from 15% to 80%, and ranges 
were dependent on the study design and the sensitivity of neuropsychological tests used 
(Jansen, Miaskowski, Dodd, & Dowling, 2007). 
Since the 1980’s, there has been a burgeoning interest in CRCI in the literature 
(Ahles, Root & Ryan, 2012; Taillibert, 2010).  CRCI has been colloquially termed 
“chemobrain” or “chemofog” and characterized by difficulty in memory, attention, 
concentration, processing speed, and executive functioning (Wefel, Kesler, Noll & 
Schagen, 2015).  Although research has emerged in relation to cancer and cognition 
across various disease sites, breast cancer has been the major focus.  This focus 
predominates due to the large breast cancer patient population who have received 
aggressive treatments, combined with continued improvements in survival rates (Siegel et 
al., 2012). 
Worldwide, breast cancer is the most common type of cancer among women, 
accounting for 23% of the total number of cancer incidence (Jemal et al., 2011).  Within 
Canada, one out of nine Canadian women is expected to develop breast cancer during 
their lifetime (Canadian Cancer Society's Advisory Committee on Cancer Statistics, 
2014).  As of 2014, the five-year relative survival rate for breast cancer in Canada was 
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88% for women and 80% for men (Canadian Cancer Society's Advisory Committee on 
Cancer Statistics, 2014).  Adjuvant chemotherapy is a regimen involved in improving 
treatment outcomes with consistent reduction in mortality (Cold, Düring, Ewertz, Knoop 
& Møller, 2005) and increased rates of survival (Canadian Cancer Society, 2015).  It is 
also known to have side-effects including, most commonly, fatigue, hair loss and 
depression (Azim Jr., Azambuja, Colozza, Bines & Piccart, 2011).   
In breast cancer, CRCI research has largely focused on neurotoxicity associated 
with chemotherapy.  Vodermaier (2009) reported that in most studies approximately 30% 
of individuals with breast cancer experience subtle cognitive decline after treatment with 
chemotherapy, with declines in cognitive functioning in survivors ranging from 17% to 
75% (Wefel et al., 2004a).  The range of cognitive complaints often attributed to CRCI 
has included: fatigue, lack of focus, mental confusion, inability to concentrate, inability to 
organize daily activities, loss of memory and memory lapses, decreased mental clarity, 
difficulties with concentrating and maintaining attention, remembering details, names and 
common words, multi-tasking and finishing certain tasks, learning new skills and slower 
thinking and processing (Taillibert, 2010).  Perceived impairment of brain function can 
affect psychological well-being, the ability to perform usual activities of daily living, and 
the ability to perform in the workplace (Munir et al., 2011).  CRCI has emerged as one of 
the most puzzling and concerning adverse effects of treatment in the breast cancer 
population.   
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Etiology of Cancer-related Cognitive Impairment 
The pathological mechanisms of CRCI are not well understood.  Many factors 
either independently or interdependently are hypothesized to influence cognitive function 
in individuals with breast cancer.  Molecular and biological factors include direct injury 
to neurons due to chemotherapy induced brain toxicity (Yang & Moon, 2013).  
Physiological factors include cytokine deregulation, genetic susceptibility, cerebral white 
or gray matter microvasculature obstruction causing direct ischemia (Ahles & Saykin, 
2007; Saykin, Ahles, & McDonald, 2003; Wefel et al., 2004), DNA damage and 
subsequent oxidative stress (Ahles & Saykin, 2007), integrity of the blood–brain barrier, 
and cognitive function prior to treatment initiation (Dietrich, 2012).  Medical 
comorbidities and demographic factors that are hypothesized to influence and affect 
cognitive function related to CRCI have not been critically investigated in individuals 
with cancer (Mandelblatt et al., 2014; Wefel et al., 2015).  These variables include: race, 
ethnicity, socioeconomic status, menopausal status, and the timing of treatment.  Also 
incorporated are combinations of different treatment modalities: the disease state, fatigue, 
pain, psychological factors such as anxiety and depression, diet and body mass index 
(Janelsins, Keslet, Ahles & Morrow, 2014; Janz et al., 2007; Nguyen et al., 2013; 
Sherwin, 2012).  During a 2003 workshop of oncologists, radiologists, psychologists and 
patient advocates, a consensus was developed to not only define and design treatment 
modalities but also develop methodological approaches around the existence of this 
clinical entity - CRCI (Tannock, Ahles, Ganz & Van Dam, 2004). 
Radiation therapy is most often used in conjunction with other treatments to 
maintain control of the disease.  It also decreases the chances of local recurrence for those 
10 
 
at higher risk (National Cancer Institute, 2014).  Radiation to the breast, chest wall or 
regional lymph nodes, similar to surgery, produces localized effects that control the 
boundaries of the cancer.  Unlike radiation to the brain, focal irradiation of the breast, 
chest-wall and regional lymph nodes have not been associated with changes in cognitive 
functioning (Shapiro & Recht, 2001).  However, this relational association has not been 
tested in large sample size studies and has been confounded with individuals receiving 
chemotherapy and/or hormone treatments.  
  
Neuropsychological Sequelae  
Neuropsychological studies in individuals with breast cancer have been 
inconclusive regarding whether or not chemotherapy alone causes cognitive impairments 
(Collins, Mackenzie & Kyeremanteng, 2013).  CRCI in this population was found in 
multiple functional domains.  The neuropsychological sequelae observed typically 
include: inefficiencies in attention and concentration (the ability to focus on incoming 
stimuli); working memory (the ability to hold and manipulate information in the mind);  
information processing speed (the ability to sustain attention, engage in visual scanning, 
and activate and inhibit rapid responses); visual memory (immediate and delayed recall 
and recognition of visual information); verbal memory (immediate and delayed recall and 
recognition of word lists or stories); language (word finding, vocabulary, and speed and 
ease of word generation); visuospatial function (ability to copy a complex two-
dimensional figure and reconstruct complex two-dimensional patterns); and organization 
(Correa & Ahles, 2008; Kayl et al., 2006; Lezak, 2004; Marin et al., 2009; Reid-Arndt et 
al., 2009; Stewart et al., 2006; Vodermaier, 2009; Wefel et al., 2004b).  
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 Although currently there are no diagnostic criteria for CRCI in individual 
survivors, the advances described in the literature are helping move the field toward this 
goal (Edelstein & Bernstein, 2014).  On an individual basis and similarly with other 
patient populations, a thorough evaluation should include an interview documenting 
change in functional status, self-reporting and family rating measures, and performance 
tests emphasizing attention, memory, processing speed, and executive functions.  
Neuropsychological tests should be valid, reliable and have good sensitivity and 
specificity (Lezak, 2004).  The test battery selected should lead the clinician to the correct 
identification of individuals who have or do not have cognitive impairment (Vardy, 
Rourke & Tannock, 2007).  In the context of clinical trials, interpretation of results has 
been complicated by a lack of standardization of the neuropsychological battery used, 
definitions of what constitutes cognitive impairment, and an understanding of how best to 
analyze the data (Tannock et al., 2004).  To address this problem, the International 
Cognition and Cancer Task Force (ICCTF) provided research recommendations and 
guidelines to increase the homogeneity of studies and to facilitate comparisons among 
studies (Wefel et al., 2011).  At a minimum, the ICCTF has recommended using a 
standardized core battery of tests that include measures of learning and memory, 
processing speed, and executive function (i.e., Hopkins Verbal Learning Test-Revised 
[HVLT-R], Trail-Making Test, and the Controlled Oral Word Association Test of the 
Multilingual Aphasia Examination [COWA]).  These tests were selected because they 
have adequate psychometric properties and have been adapted to be used with other 
languages.  In addition, the COWA and HVLT-R have alternative forms available that 
assist with serial testing.  The ICCTF also recommended common criteria for defining 
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cognitive impairment and cognitive changes.  Impaired cognitive performance can be 
defined as scoring 1.5 standard deviations (SDs) below published norms on two tests or 
scoring 2.0 SDs below published norms on one test (Wefel et al., 2011).  The 
recommendations brought forth by the ICCTF could improve the homogeneity of study 
methods.  Standardization and comparison among cognitive studies will provide more 
accurate information about incidence, severity, and risk factors for impairment.  
Results of objective neuropsychological assessments have not always 
corroborated the deficits reported by individuals.  Several studies (Biglia et al., 2012; 
Hutchinson, Hosking, Kichenadasse, Mattiske & Wilson, 2012; Pullens, De Vries, Van 
Warmerdam, Van De Wal, & Roukema, 2013; Shillings & Jenkins, 2007; Vardy & 
Dhillon, 2011) have reported a weak association between subjective reports of cognitive 
impairment and objective neuropsychological test results.  Hutchinson, et al. (2012) 
reported the individual’s perception of cognitive impairment was generally worse than 
that detected on objective assessment.  Shilling and Jenkins (2007) suggested that self-
reporting is necessary to define the impact of the subtle cognitive deficits caused by 
treatment on daily functioning and quality of life as exemplified by the impact of 
cognitive deficits on career and educational decisions, on activities of daily living, and on 
general quality of life.  Vardy and Dhillon (2011) suggested the apparent disconnection 
between neuropsychological test performance and self-reported cognitive function exists 
because different constructs of cognitive impairment are measured.  Although 
individuals’ subjective perceptions of health are important, cognitive impairment is best 
measured by objective tests because subjective impairment is often associated with 
emotional components such as anxiety, depression and physical distress (e.g. pain).  
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Subjective cognitive complaints should be taken into account in the assessment of the 
individual’s well-being, but it cannot be used as a substitute for objective cognitive 
measures, especially when making decisions about health, work and/or other major life 
decisions (Green, Pakenham & Gardiner, 2003).  
Regardless of the objective-subjective assessment difference in measurement 
tools, cognitive impairment can cause substantial distress to many survivors (Schagen et 
al., 2014).  A more comprehensive picture emerges with the combined incorporation of 
both subjective and objective measures of cognitive dysfunction.  Simultaneously using 
both subjective and objective measures of cognitive dysfunction have provided a more 
complete picture of rehabilitation targets in cancer survivors (Gehring, Taphoorn, 
Sitskoorn & Aaronson, 2015). 
 
Interventions 
Interventions for CRCI can be pharmacological, non-pharmacological, or both.  
Pharmacologic management has been studied, and yet no known agent has been approved 
to combat these symptoms (Gehring, Roukema & Sitskoorn, 2012; Schagen et al., 2014).  
To date, the evidence does not support the efficacy of the pharmacological approaches of 
psychostimulants or erythropoietin (Von Ah, Storey, Jansen & Allen, 2014; Chan, 
McCarthy, Devenish, Sullivan & Chan, 2015).  Research is limited regarding donepezil 
in individuals with cancer (Jatoi, Kahanic, Frytak, Schaefer, Foote, Sloan & Petersen, 
2005; Rapp et al., 2015).  Antioxidants, including vitamin E and Ginkgo biloba, were not 
efficacious in the limited trials conducted (Von Ah, Jansen, & Allen, 2014).  Within the 
broader context of non-pharmacological interventions, cognitive rehabilitation 
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approaches are emerging as an important and viable treatment option for cancer survivors 
experiencing cognitive problems.  The cognitive rehabilitation approaches will be the 
focus of the present review.   
 
Cognitive Rehabilitation Therapy 
 The fundamental theory of cognitive rehabilitation therapy (CRT) was developed 
from the efforts to treat individuals who suffered from brain injury or stroke.  The Brain 
Injury Interdisciplinary Special Interest Group of the American Congress of 
Rehabilitation Medicine endorses the most commonly referenced definition of cognitive 
rehabilitation:  
Cognitive rehabilitation is defined as a systematic, functionally oriented service of 
therapeutic cognitive activities, based on an assessment and understanding of the 
person's brain-behaviour deficits.  Specific interventions may have various 
approaches, which include: i) reinforcing, strengthening or re-establishing 
previously learned patterns of behaviour; ii) establishing new patterns of cognitive 
activity through compensatory cognitive mechanisms or impaired neurological 
systems; iii) establishing new patterns of activity through external compensatory 
mechanisms such as personal orthoses or environmental structuring and support; 
vi) enabling persons to adapt to their cognitive disability, even though it may not 
be possible to directly modify or compensate for cognitive impairments, in order 
to improve their overall level of functioning and quality of life. (Cicerone et al., 
2000, p. 1596-1597) 
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This description allows for comprehensive, interdisciplinary rehabilitation programs with 
interventions to restore or reorganize function, compensates for impaired function 
through new cognitive patterns or external devices, and enables individuals to adapt to 
their new level of function.   
The principles of CRT indicate that specific techniques alone are not adequate for 
effective rehabilitation.  Instead, an integrated approach that addresses cognitive, 
emotional and motivational aspects of functioning is necessary (Clare, Wilson, Carter, & 
Hodges, 2003).  CRT acknowledges the complex interactions among techniques 
including the social, emotional, and interpersonal contexts.  These contextual aspects may 
help to target specific cognitive domains such as attention, memory, executive 
functioning.  Various types of delivery models for cognitive rehabilitation methods 
should help target and improve the social, emotional, and interpersonal contexts.  
Cognitive rehabilitation strategies have been found to improve function in individuals 
with subtle to severe cognitive deficits (Cicerone et al., 2000; Sohlberg & Mateer 2001; 
Wilson, 2000).  
 Most research on the effectiveness of cognitive rehabilitation was directed 
towards improving neuropsychological and behavioural performance in adults.  In two 
comprehensive reviews of evidence-based studies on brain injury rehabilitation, Cicerone 
and co-authors (Cicerone et al., 2000, 2005) determined that remediation, although 
typically characterized by small-to-moderate treatment improvements, is an effective 
therapeutic process.  The National Academy of Neuropsychology and National Institute 
of Health published consensus statements that arrived at the same conclusion (National 
Academy of Neuropsychology, 2002; Ragnarsson, 2002).  
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Family Involvement in Cognitive Rehabilitation Therapy 
Emotional stress, perceived burden of caretaking and disrupted family 
functioning, as well as the unmet needs of other family members may contribute to 
unhealthy family communication or functioning (Koehler, Wilhelm & Shoulson, 2011).  
Rummans et al., (2006) emphasized addressing the five key domains of quality of life 
(physical, mental, social, emotional, and spiritual) and developed an effective 
multidisciplinary intervention for patients with advanced cancer (Clark et al., 2013).  
Clark et al., (2013) conducted a study targeting the five domains of quality of life among 
caregivers and patients with advanced cancer who received radiotherapy.  Dyads were 
randomly assigned to a 6-session, structured, multidisciplinary intervention arm or a 
standard care arm.  Results demonstrated the multidisciplinary intervention was effective 
in maintaining the quality of life of patient participants; however, the intervention did not 
impact the quality of life for caregivers.  Caregivers suggested that their needs could have 
been better addressed in a separate caregivers-only group.  Many stated they did not want 
to discuss their challenges of cancer caregiving around their loved ones, or even in the 
presence of other cancer patients.  They believed discussing their burden with other 
caregivers would have been beneficial to them.  Based on a review by Hopkinson, 
Brown, Okamoto and Addington-Hall (2012), the authors concluded that if patient-family 
interventions included a component to facilitate interaction within the pair, a pattern of 
improvement emerged in the emotional health of both cancer patients and their 
caregivers.   
A study evaluated a structured educational program directed to caregivers of 
patients diagnosed with a malignant glioma (Cashman et al., 2007).  Program content 
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included brain tumor biology and treatment, symptom and adverse effect management, 
safety in the home, the role of palliative care, brain behavior relationships, understanding 
and coping with cognitive changes, and obtaining psychosocial support.  Twenty-four 
caregivers participated, and assessment showed that knowledge was significantly 
improved.  The program was favorably evaluated by participants.  Participants also 
appreciated the opportunity to interact with other caregivers. 
Achieving the goals of CRT involves working collaboratively with the client, 
family members or other support persons in the client’s life and accommodating 
cognitive impairments and environmental variables relevant to the individual (Sohlberg 
& Mateer, 2001).  Research has been limited regarding the benefits of actively including 
caregivers in oncological cognitive rehabilitation interventions.  Locke et al., (2008) 
conducted a pilot study to determine the feasibility and tolerability of a combined 
cognitive-rehabilitation and problem-solving-therapy intervention for patients with brain 
tumors and their caregivers.  Nineteen patient/caregiver pairs were enrolled and 
randomized.  Thirteen pairs completed the 2-week trial.  After receiving the intervention, 
88% of patients used the study-specific strategies, and 88% indicated that they would 
recommend the intervention to other patients diagnosed with a brain tumor.  The study 
intervention was described as "very helpful" or "somewhat helpful" by 88% of study 
participants.  Caregivers were similarly enthusiastic about the intervention.  The results 
showed that patients with brain tumors who have cognitive impairment can participate 
meaningfully in a structured intervention.  Patients supported further research into the 
potential effectiveness of formal rehabilitation targeting cognitive and QOL symptoms 
for patients with brain tumors and their caregivers.  The changes in cognitive and/or 
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behavioural functioning caused by brain injury, not only affects the individual, but also 
places enormous demands on families.  The effects on individuals with breast cancer are 
just as challenging. 
Successful rehabilitation for individuals with breast cancer involves cooperation, 
participation, and encouragement from the individuals’ support network.  Long-term 
treatment efforts require collaboration among health care professionals, clients, and their 
families (Levack et al., 2009).  Garnering family support throughout the treatment 
process captures a unique resource to sustain treatment effects, provide generalization 
from theoretical and clinical application to real-life situations, and facilitates ongoing 
recovery.  These partnerships can help ensure realistic treatment goals are met by valuing 
and acknowledging the expertise, needs and concerns of the individual and family 
(Sohlberg & Mateer, 2001).  
 
Cognitive Rehabilitation and Cancer  
As advances in medical treatments enable individuals with cancer to live longer, 
they allow health care providers to focus their attention on the individual’s psychological 
state and quality of life.  The need for psychosocial support for women with breast cancer 
has increasingly been recognized.  As a result, a variety of interventions were developed 
to treat the emotional impact of the disease (Fors et al., 2010; Hoffman et al., 2012).  In 
the last three decades, substantial growth in the number of support groups available to 
individuals with cancer has risen, mostly within hospital settings.  Support groups have 
become increasingly popular, due to their cost-effectiveness, including the use of peer 
support.  Cameron et al. (2005) studied women diagnosed with breast cancer and their 
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decisions to participate in group support programs.  The authors concluded that 
psychosocial support programs and informational materials promoting their use may 
attract more participants if they are tailored to focus on resolving cancer-related distress 
rather than on general anxiety or depression.  Cognitive rehabilitation is extensively used 
in many clinical populations that experience cognitive impairment; however, there is a 
scarcity of research regarding its use in individuals with cancer.  
While cancer and cognition research has primarily been focused on elucidating 
the profile of CRCI in non-CNS tumours, few studies have focused on interventions to 
assist individuals once their cognitive deficits emerge.  Schuurs and Green (2013) cited 
four published studies examining the true potential for cognitive rehabilitation to improve 
cognitive dysfunction in non-CNS tumours in adults.  Gehring et al. (2009) posited that 
cognitive intervention programs may improve functioning and Von Ah et al. (2011) 
postulated against improvement.  Closer examination of studies revealed that, to date, 
cognitive strategies or interventions tend to lead to improvements in subjective memory, 
but not necessarily objective memory test scores.  Interventions based on self-regulatory 
cognitive rehabilitation show some promise.  Additionally, interventions using relaxation 
techniques (e.g., meditation, exposure to the natural environment) may improve attention 
following breast cancer surgery. 
 A single-arm pilot study by Ferguson et al. (2007) also appeared to have potential 
to improve cognitive dysfunction in individuals with breast cancer who underwent 
chemotherapy.  Twenty-nine BCSs underwent neuropsychological training using 
Memory and Attention Adaptation Training (MAAT) eight years after chemotherapy.  
The MAAT consists of a participant workbook, four individual monthly visits of 30–50 
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minutes and three telephone contacts among visits.  Results demonstrated improvements 
in objective measures of cognitive function and improved stress management in dealing 
with memory problems in everyday life at a two-month, and a six-month follow-up 
interval.  Similar results were found in a waitlist control trial.  At the two-month follow-
up, participants demonstrated significant improvements on the spiritual subscale of the 
quality-of-life measure and on verbal memory, relative to controls.  However, changes in 
self-reported cognitive function were inconclusive. 
 Poppelreuter, Weis, and Bartsch (2009) compared the effects of group-based 
cognitive training and individualized training on cognitive impairment in individuals with 
breast cancer who received adjuvant chemotherapy.  Neither form of training resulted in 
cognitive improvements equal to or greater than those observed over time in a non-
treatment control group.  Several factors may have contributed to the null results.  
Participants were recruited shortly after they completed chemotherapy which correlates 
with periods when spontaneous recovery of cognitive function is most likely to occur.  
On the contrary, Ferguson et al. (2007) evaluated participants who had completed 
chemotherapy at least 18 months (Ferguson et al., 2012) or 3 years previously (Ferguson 
et al., 2007).  Poppelreuter et al. (2009) concluded that, during this narrow time frame 
immediately after chemotherapy, interventions aimed at improving cognitive outcomes 
may not be effective or necessary.  Following completion of treatment, individuals are 
more likely to be dealing with many other important issues, and confronting cognitive 
deficits at this time may be psychologically disturbing (Fardell, Vardy, Johnston, & 
Winocur, 2011). 
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 A recent study using a computerized cognitive training program (Kesler et al., 
2013) included 41 BCSs who were randomly assigned to the active treatment group 
(n=21) and a 12-week waitlist (n=20).  Inclusion criteria were a history of stages I-III 
breast cancer, a history of breast cancer treatment including surgery and adjuvant 
chemotherapy (participants were not excluded for radiation or hormonal therapies), a 
minimum age of 40, and at least 18 months post-chemotherapy to allow for neural 
stabilization.  The participants completed a session of five exercises four times weekly 
for 12 weeks, with each session lasting approximately 20-30 minutes.  Exercises included 
switching, mental rotation, working memory, spatial sequencing, word stem completion, 
route planning and rule-based puzzle solving.  The active treatment group experienced 
significant improvements in cognitive flexibility, verbal fluency, processing speed, and a 
trending improvement on verbal memory as assessed by the Wisconsin Card Sorting 
Task, the letter fluency test from the Delis-Kaplan Executive Function System, the 
Symbol Search subtest of the Wechsler Adult Intelligence Scale 4
th
 edition, and the 
Hopkins Verbal Learning Test-Revised, respectively.  Although not significant, the active 
group also showed reduced self-rated symptoms of everyday executive function problems 
(i.e., the global executive composite score of the Behavioral Rating Inventory of 
Executive Function-Adult version).  
 Although CRCI has been described and investigated in many studies, there is a 
lack of information in specific neuropsychological training programs in cancer 
rehabilitation.  More research is needed to systematically investigate the effects of 
specific neuropsychological rehabilitation strategies in individuals with breast cancer 
patients after completion of active treatment.  
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Chapter 3: Methods 
This study was conducted in an ambulatory outpatient neuropsychology clinic in 
Northeastern Ontario, over the course of nine months.  Participants were recruited via 
direct referrals from the cancer site, a newspaper advertisement, a breast cancer 
information website, and a radio interview.  Study information was emailed to all staff 
and posted throughout the site.  Methods were approved by the research ethics boards of 
the site where the research was conducted as well as from the affiliated university.  
Participants 
Six breast cancer survivors (BCSs) and their training partners participated in this 
study.  Enrolment criteria specified that the BCSs:  
1. had previously received a diagnosis of stages I - III breast cancer; 
2. were between 18 and 60 years of age at time of recruitment; 
3. were medically stable for a minimum of 3 months prior to the time of recruitment 
(i.e., no evidence of recurrent disease) or a secondary cancer diagnosis, and no 
anti-tumour treatment during that period of time (i.e., radiotherapy, 
chemotherapy, corticosteroids); 
4. possessed adequate English proficiency to complete neuropsychological 
assessments; 
5. reported at least one symptom of impaired cognitive functioning based on a self-
report symptom checklist administered by the researcher; 
6. demonstrated neuropsychological impairment at baseline, defined as a z-score  ≤ 
-1.0 on two tests compared to the normative mean and, 
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7. were able to understand and be willing to sign a written informed consent 
document before enrolling in the study. 
BCSs were required to have a designated training partner identified as: 
1. a family member or close friend identified by the survivor; 
2. having a minimum of a weekly face-to-face contact with the survivor; 
3. at least 18 years of age; 
4. having  an adequate English proficiency to complete questionnaires; 
5. available to come to the assessment and intervention sessions; and 
6. able to provide written informed consent before enrolling in the study.   
BCSs were excluded on the basis of the following criteria:  
1. pre- and/or co-existing condition impairing cognition; 
2. neurological or psychiatric condition sufficient to preclude providing informed 
consent; 
3. poor proficiency in English;  
4. history of mental retardation or IQ below 85; 
5. life expectancy less than one year due to malignant disease; 
6. recent and/or concurrent participation in cognitive rehabilitation, psychological 
intervention, drug trials, or neuropsychological testing.  
 
Demographics/Clinical Characteristics 
 Demographic data for all participants collected through use of a self-report 
questionnaire at baseline included their age, gender, race/ethnicity, marital status, and 
education.  The BCSs clinical characteristics were obtained through review of individual 
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medical charts.  All variables obtained included: cancer type, date of diagnosis, type of 
treatments received (surgery, chemotherapy, and/or radiation), TMN (tumour, node and 
metastases) staging, current prescribed medications, and menstrual status. 
 
Assessment of Neuropsychological Performance 
 Cognitive function was assessed using a battery of neuropsychological tests that 
were selected based on validity, reliability, and their use with BCSs in published 
literature.  The tests and questionnaires were administered in a standardized fashion.  
Scoring followed standardized procedures.  To minimize the influence of practice effects, 
alternate forms were used where available.  Baseline assessments (T0) took place prior to 
the start of the cognitive rehabilitation program (CRP).  Follow-up assessments were 
conducted directly after the 10-week treatment phase (T1) and approximately 20-weeks 
after baseline assessment (T2).  
 The assessment battery was designed to assess function across several cognitive 
domains: language skills, memory, attention, concentration, information processing 
speed, motor functioning, visuospatial functioning, problem solving, and mental 
flexibility.  The assessment used the following tests: Benton’s Judgement of Line 
Orientation (JOLO; Benton, Varney, & Hamsher, 1978); Boston Naming Test-Second 
Edition (BNT-2; Kaplan, Good glass, & Weintraub, 2001);  Brief Visuospatial Memory 
Test-Revised (BVMT-R; Benedict, 1997);  Conners' Continuous Performance Test- 
Second Edition (CPT-2; Conner’s, 2004);  Controlled Oral Word Association Task 
(COWAT; Spree & Strauss, 1998);  Grooved Pegboard (GP; Reitman & Wolfsan, 1985);  
Grip Strength (Grip Strength; Reitman & Wolfsan, 1985);  Hopkins Verbal Learning 
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Test-Revised (HVLT-R; Brandt & Benedict, 2001);  Lateral Dominance Examination 
(LDE; Reitman & Wolfson,1985);  Trail Making Test A and B (TMT-A/B; Reitman & 
Wolfsan, 1985);  Wechsler Test of Adult Reading (WTAR; Pearson, 2001);  Digit Span 
of the Wechsler Adult Intelligence Scale- Third Edition (WAIS-III) (DS; Wechsler, 
1997);  Digit Symbol-Coding of the WAIS-III (Cd; Wechsler, 1997); Letter-Number-
Sequencing of the WAIS-III (LNS; Wechsler, 1997);  Wisconsin Card Sorting Test, 
Computer Version 4 (WCST-CV4; Heaton & PAR Staff, 2003).  Test descriptions are 
summarized in Table 1. 
 
Self-reported Domains of Functioning  
 Self-reported cognitive dysfunction was measured using the Perceived Deficits 
Questionnaire (PDQ) and the Behavior Rating Inventory of Executive Function – Adult 
version (BRIEF-A) Self Report.  The standardized self-report quality of life measures 
used included the European Organization for Research and Treatment of Cancer-Core 
Quality of Life Questionnaire (EORTC QLQ-C30) and breast cancer Specific Quality of 
Life Questionnaire (EORTC QLQ-BR23), Beck Depression Inventory-II (BDI-II), Beck 
Anxiety Inventory (BAI), and the Brief Symptom Inventory-18 (BSI-18).  The training 
partners were administered the Caregiver Quality of Life Index-Cancer (CQOLC) and the 
BRIEF-A, Informant Report. 
The PDQ (Sullivan, Edgily, & Detox, 1990), consisting of 20 items, is part of the 
Multiple Sclerosis Quality of Life Inventory assessing self-perceived difficulties with 
organization, concentration, and memory during the previous month.  Scores range from 
20 to 100, with a higher score signifying greater perceived cognitive dysfunctions.  The 
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PDQ has been shown to have good reliability and validity in persons with multiple 
sclerosis (Cronbach's alpha .77-.97).  Although there is no psychometric data available 
for individuals with mild cognitive impairment, the questions are relevant to mild 
cognitive impairment (Dowdy et al., 2009). 
 The BRIEF-A (Roth, Squish, & Goya, 2005) is a 75-item questionnaire designed 
to assess executive functioning in daily life spanning the previous month.  The inventory 
yields nine scales (Inhibit, Shift, Emotional Control, Self-Monitor, Initiate, Working 
Memory, Plan/Organize, Task Monitor, and Organization of Materials).  T-scores are 
calculated for each of the clinical scales and indices (Metacognition and Behavioral 
Regulation) and for the summary (Global Executive Composite, GEC).  T-scores are 
based on comparison to the normative sample comprised of 1050 self-reports, with higher 
scores reflecting greater difficulty.  The BRIEF-A has been shown to have reliability and 
validity.  Test-retest reliability across the clinical scales ranged from 0.82 - 0.93 over an 
average interval of 4.22 weeks for the Self-Report Form and from 0.91 - 0.94 over an 
average interval of 4.21 weeks for the Informant Report Form.  Correlations between 
Self-Report ratings and Informant Report ratings were moderate, ranging from 0.44 - 
0.68 for the clinical scales and from 0.61- 0.63 for the indexes and the GEC.   
 Psychological health status was evaluated using the Brief Symptom Inventory-18 
(BSI-18).  The BSI-18 is an 18-item version of the 53-item BSI that is derived from the 
Symptom Checklist-90.  Items are rated on a five-point Likert scale items (0 = “not at 
all”; 4 = “extremely”) exploring the degree to which particular problems have distressed 
or bothered the respondent during the last seven days.  These items constitute the 
standardized self-report symptom inventory designed to serve as a screen for depression, 
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somatization, and anxiety in medical and community populations (Derogates, 2000).  
Responses to all 18 items are summed to determine a Global Severity Index (GSI).  
Cronbach's alpha as a measure of internal reliability for this sample was 0.88 for the 
depression subscale, 0.70 for somatization, and 0.79 for anxiety.   
 The BAI (Beck & Steer, 1990) is a 21-item self-report measure designed to assess 
generalized anxiety.  The respondent is asked to rate how much each symptom has 
bothered him or her in the past week.  The symptoms are rated on a four-point scale, 
ranging from ‘‘not at all’’ (0) to ‘‘severely’’ (3).  The BAI has a high internal consistency 
(Cronbach’s α= 0.92) and a test-retest reliability over one week of 0.75 (Beck, Epstein, 
Brown, & Steer, 1988).  The reliability and validity of the BAI have been demonstrated 
in a variety of clinical populations, including individuals with cancer (Vodermaier, 
Linden, & Siu, 2009). 
 The BDI–II (Beck, Steer, & Brown, 1996) consists of 21 items designed to assess 
symptoms of depression based on the diagnostic criteria in the DSM-IV experienced 
during the previous two weeks.  Each item contains four statements reflecting varying 
degrees of symptom severity.  Respondents are instructed to circle the number (ranging 
from zero to three, indicating increasing severity) that corresponded with the statement 
that best described them.  Ratings are summed to calculate a total BDI–II score.  The 
BDI-II yields a coefficient alpha of 0.92 for the outpatient population (n = 500) in the 
sample referenced in the manual.  In addition, a one-week test-retest correlation of 0.93 
resulted from a study of 26 outpatients who had been referred for depression and took the 
BDI-II during their first and second therapy sessions (Beck, Steer & Brown, 1996). 
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 Health-related quality of life was assessed with the EORTC QLQ-C30 and BR23 
(Foyers, Aaronson, Boral, Groenvold, Curran & Bottomley, 2001), a questionnaire 
developed for use in clinical trials involving cancer patients.  The validity, reliability, and 
sensitivity when administered to cancer patients are well established (Aaronson, 
Ahmedzi, Bergman, Bullinger, & Cull, 1993).  The EORTC QLQ-30 is a 30-item 
questionnaire that consists of five functional scales (physical, role, cognitive, emotional, 
and social functioning), three symptom scales (fatigue, pain, nausea and vomiting), and a 
general health and quality-of-life scale.  Five single items measure complaints often 
mentioned by cancer patients (loss of appetite, dyspnea, sleep disturbance, constipation, 
and diarrhea).  The BR23 breast cancer module is designed to capture effects due to 
treatment.  Twenty-three items are organized into four symptom scales (systemic therapy 
side effects, breast symptoms, arm symptoms, and upset by hair loss) and four functional 
subscales (body image, sexual functioning, sexual enjoyment, and future perspective).  
The scoring algorithm recommended by the EORTC is used to transform the responses to 
values on a scale of 0% to 100%.  For the functional scales and global quality of life, a 
higher score corresponds to better functioning and quality of life.  For symptom scales, a 
higher score corresponds to more frequent and/or more intense symptoms.  The test-retest 
correlation over a four-day interval ranged from 0.82-0.91 (Aaronson, Ahmedzi, 
Bergman, Bullinger, & Cull, 1993). 
 The CQOLC (Weitzner, 1999) is a 35-item rating scale using a five point Likert-
type scale to assess quality of life with family caregivers of cancer patients.  The 
questionnaire was developed based on semi-structured interviews with patients, family 
caregivers and health care professionals.  The instrument measures the impact of helping 
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a family member with cancer has on the caregiver's perception of quality of life.  The 
CQOLC scales measure physical, emotional, family, and social functioning burden.  It 
also includes items of spirituality, financial, and economic issues.  The CQOLC scale is 
scored by adding up the score on each item to yield a total score for the instrument.  
Lower scores reflect better quality of life.  The CQOLC has undergone formal 
psychometric testing demonstrating validity and reliability.  Reliability was established 
by test-retest analysis over a period of three weeks at 0.95 and internal consistency 
measured by Cronbach’s alpha was 0.91 (Weitzner, 1999). 
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Table 1. Neuropsychological Measures 
 
Test Ability Test Description 
Test-retest 
reliability 
Author 
WTAR 
Pre-morbid level of 
intellectual functioning 
Reading test composed of a list of 50 words 
that have atypical grapheme to phoneme 
translations.  
Ages 16-89 
0.90-0.94 
Psychological 
Corporation, 2001 
WAIS-III DS 
Immediate verbal 
attention span, verbal 
working memory 
Involves forward and backward repetitions 
of series of digits 
Ages 16-64 
0.88 
Weschler, D, 2001 
WAIS-III Cd 
Focused attention, 
graphomotor speed, 
visual scanning, 
incidental memory 
Pairing numbers to nonsense symbols as 
quickly as possible 
0.83 Weschler, D, 2001 
WAIS-III LNS 
Alternating attention; 
verbal working 
memory 
Involves reading a sequence of numbers 
and letters and recalling the numbers in 
ascending order and the letter in 
alphabetical order 
0.85 Weschler, D, 2001 
CPT-2 
Sustained attention, 
vigilance, reaction time 
Computerized program that requires 
responding to the stimuli on a computer 
screen by pressing a space bar for every 
letter except for the letter "X." 
Omissions – 0.84 
Commissions – 0.65 
Detectability - 0.76 
Conners & MHS 
Staff, 2000 
TMT-A 
Focused visual 
attention 
The examinee must draw lines to connect 
consecutively numbered circles on the 
work sheet 
0.79 * 
Strauss, Sherman, 
Spreen, 2006 
TMT-B 
Divided attention, 
cognitive flexibility 
The examinee must draw lines to connect 
the same number of consecutively 
numbered and lettered circles on the 
worksheet by alternating between the two 
sequences 
0.89* 
Strauss, Sherman, 
Spreen, 2006 
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Table 1 (continued)   
Test Ability Test Description 
Test-retest 
reliability 
Author 
WCST:CV4 
Novel problem-
solving, concept 
formation, set 
maintenance 
The examinee is asked to match a series of 
response cards that have various forms that 
vary in colour and number, to one of four 
static stimulus cards. 
Across measures 
0.12 - 0 .66 
Heaton et al., 2003 
COWAT 
Phonemic fluency. 
semantic fluency 
Phonemic - Examinees were required to 
generate orally as many words as possible 
that begin with the letters F, A, or S (1 min 
each). 
 
Semantic – The examinee is asked to 
generate as many names of animals as 
possible over a 1-min period. 
>0.70 
Strauss, Sherman, 
Spreen, 2006 
BNT-2 
Confrontation naming, 
object gnosis, 
The examinee is presented with 60 
drawings of objects and instructed to give 
the objects’ names. 
0.91 
Strauss, Sherman, 
Spreen, 2006 
HVLT-R 
Verbal memory and 
recall 
The examinee is required to recall of a 
series of 12 words over three learning 
trials, free recall after a delay, and a 
recognition trial 
Total Recall 0.74 
Delayed Recall 0.66 
Brandt & Benedict, 
2001 
BVMT-R 
Visuospatial learning 
and recall 
The examinee is required to learn a matrix 
of six simple abstract designs (presented 
for 10 seconds) over three trials, and then 
delayed recall and recognition (yes/no) are 
assessed after 25 min. 
Total Recall 0.80 
Delayed Recall 0.79 
Benedict, 1997 
JOLO Visuospatial judgment 
The examinee is required to visually judge 
the angle between two full or partial lines, 
which is compared to a multiple choice 
display of 11 numbered lines carrying in 
their degree of angular orientation.   
37 participants 
administered both 
versions; 6 hours – 21 
days), 0.90 
Benton, Hamsher, & 
Varney, 1983 
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Table 1 (continued)   
Test Ability Test Description 
Test-retest 
reliability 
Author 
Lateral 
Dominance 
Examination  
Hand foot, and eye 
dominance 
Consists of a series of performances used 
to determine the examinee’s preference for 
use of hand, food and eye. 
 
Reitan & 
Wolfson, 1985 
Grooved 
Pegboard  
Manual dexterity, 
visuomotor- 
coordination, speed 
The examinee is asked to put pegs in holes 
as quickly as possible with their left and 
right hand. The number of pegs put in the 
pegboard is also counted also as an 
indication of motor speed. 
0.67 – 0.86 
Reitan & 
Wolfson, 1985; 
Strauss, Sherman, 
Spreen, 2006 
Hand 
Dynamometer  
Grip strength 
The examinee squeezes the dynamometer 
to assess grip strength.  
0.52 -.0.96 
Reitan & 
Wolfson, 1985; 
Strauss, Sherman, 
Spreen, 2006 
Note: WAIS-III Cd – US test-retest reliability coefficients reported;  BNT = Boston Naming Test; BVMT-R = Brief 
Visuospatial Memory Test-Revised; COWAT = Controlled Oral Word Association Test - FAS and Animals; CPT-2 = 
Conners' Continuous Performance Test-2; HVLT-R = Hopkin's Verbal Learning Test –Revised; JOLO = Judgment of Line 
Orientation; TMT-A = Trail Making Test A; TMT-B = Trail Making Test B; WAIS-III Cd; Wechsler Adult Intelligence Scale 
- Third Edition Digit Symbol Coding; WAIS-III DS = Wechsler Adult Intelligence Scale - Third Edition Digit Span; WAIS-III 
LNS = Wechsler Adult Intelligence Scale - Third Edition Letter-Number Sequencing; WCST = Wisconsin Card Sorting Test; 
WTAR = Wechsler Test of Adult Reading 
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Cognitive Rehabilitation Program 
Program development. A ten-week CRP was originally developed and piloted 
for relatives and patients with an acquired brain injury at the Glenrose Rehabilitation 
Hospital in Edmonton, Alberta.  The purpose of the Glenrose Rehabilitation Hospital 
program was to improve cognitive functioning (attention, memory, and concentration) 
and participation in activities that may be due to the presence of a variety of cognitive 
and behavioural problems.  Involvement of a family member or close friend helped to 
ensure that skills were maintained and applied to novel situations by using compensatory 
strategies.  The involvement also facilitated communication about how current or 
possible future difficulties might be managed.  The current CRP was further developed 
and enhanced, including the creation of a manual to guide the implementation of the 
CRP.   
Goals of program. The goals of the program were 1) to teach, practice, and 
increase the use of strategies related to attention, executive functioning, memory and 
emotions for BCSs and their training partners; and 2) to help improve thinking and 
communication skills, and overall quality of life. 
Program content. Survivors and their training partners were taught 
communication, relaxation and cognitive strategies.  There were five pillars to the 
program (see Table 2).  
Homework was an essential and effective component of therapy.  Due to the 
condensed number of sessions in this CRP, homework such as reading, behaviour 
monitoring, and new skills were given to the participants to practice and use outside the 
sessions.  Pre-planned homework exercises were designed for every sessions of the 
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program.  The homework assignments were designed to help facilitate skill acquisition, 
treatment compliance and symptom reduction by integrating the concepts learned in 
sessions into daily life.  The homework was a key mechanism for facilitating between-
session work and progress.  The following protocol was adapted from the original pilot 
study and used as a general guideline for the group sessions.  Sessions did vary according 
to the specific needs of the participants.  
 
Table 2. Five Pillars of the Cognitive Rehabilitation Program 
1) Communication and Relaxation Strategies (2 Weeks) - Strategies for enhancing 
communication and improving social interactions 
Week 1: Course review; Communication strategies  
Week 2: Sleep hygiene;  Breathing/Relaxation strategies  
2) Focused, Selective and Sustained Attention, (2 Weeks) - Strategies for addressing 
and improving attention to tasks and behaviour 
Week 3: Defining attention; Selective attention; Strategies to reduce distractions  
Week 4: Sustained attention; Preparing to pay attention 
3) Inhibitory Control , Divided Attention, Task-Switching, and Multi-tasking (2 
Weeks) - Strategies for coping with many demands at the same time 
Week 5: Implications of attention problems for daily functioning. 
Week 6: Self-regulation; Impulse control/inhibition 
4) Organization, Problem-Solving, and Reasoning (2 Weeks) - Strategies for solving 
problems as one encounters them on a daily basis 
Week 7: Goal-setting – S.M.A.R.T. goals; Organization/Planning; Reasoning/Problem 
solving   
Week 8: Goal management training   
5) Goal-Directed Behaviour, Planning, and Decision-making (2 Weeks) - How to 
organize your thoughts to make decisions and generate, plan, and execute short- 
and long-term goals 
Week 9: Goal management training continued 
Week 10: Summary of the former sessions: general overview of the training 
 
 Baseline assessment (including pre-treatment interview and assessment).  
Participants arrived at the neuropsychology clinic at the cancer site to complete a two to 
three hour interview that included the neuropsychological battery and several 
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questionnaires as described previously.  During this assessment, all participants signed an 
informed consent form after receiving both verbal and written information about the 
study procedures, confidentiality and privacy.  The purpose of the initial assessment was 
to assess the participant’s current problems and concerns.  In addition to evaluating the 
BCS, the interview was used as an opportunity to start building rapport and interest in the 
CRP, and to instil hope.  After completion of the interview, participants’ tests were 
scored within 72 hours.  The neuropsychological tests were used to determine 
participants’ eligibility for program admission and to establish baseline data.  Participants 
were informed of their eligibility via telephone and start date of the CRP.  
Program delivery.  The ten-sessions were designed to be conducted weekly in a 
group format.  One main advantage in starting with a slightly higher group size than what 
is considered ideal was the issue of attrition.  The groups were facilitated by a 
neuropsychologist and a master’s level social worker, both having experience working in 
oncology.  A psychology graduate student was also part of the facilitation team.  
Participants attended two-hour sessions with two breaks of 5-10 minutes midway in the 
session.  The neuropsychologist also provided several hours of homework to the BCSs. 
The CRP sessions consisted of three phases:  1) a check-in and teaching phase 
with the survivor and training partner; 2) a teaching and practice phase where the 
survivor and training partner groups separated (see Figure 1), the survivor group worked 
on direct metacognitive strategies; whereas, the training partner group worked on 
strategies to assist in compensating for deficits; and 3) a combined practice phase 
occurred where both groups reunited and there was a combined (survivor + partner) 
practice session.  
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Figure 1. Schematic of cognitive rehabilitation session format. 
 
 The program maintained a consistent format.  All sessions were held in the same 
room, on the same day of the week (with one exception due to a prior booking of the 
room at that time), and at the same time of day in order to provide enhanced structure for 
patients with mild cognitive deficits.  Because participants could be easily distracted, 
facilitators needed to be active and directive in engaging the group in relevant 
discussions, setting limits, and adhering to the structure and format of the session.  In 
addition, to ensure privacy and comfort, the group meetings were held in a quiet private 
meeting room that could be split into two sections with a dividing wall.  The meeting 
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rooms were situated where participants would be free of distractions (i.e. staff 
interruptions, unit announcements) and there were no windows in order to help 
participants focus on the session content and maximize attention/concentration abilities.  
It was also important that the facilitators limit the amount of time lecturing the 
participants.  It was essential that the facilitators solicit input and reactions from the 
participants during the teaching sections to engage their interests and prevent distraction.  
 Material was presented using different modalities (visual, verbal, and written).  
The teaching sections were presented using Microsoft PowerPoint slides and handouts 
were provided for the participants to write notes and take home.  Frequently engaging 
participant comprehension was important to verify understanding of the session 
materials.  Since patients with mild cognitive deficits are less inclined to initiate 
discussions and/or ask questions when they do not understand a point, facilitators 
assessed group members' understanding by requesting that they describe or summarize 
the topic in their own words, give feedback and opinions, or provide concrete examples. 
Session one.  All subsequent sessions began with an agenda for the session.  
Members were introduced to one another and the purpose of the CRP was reviewed.  The 
facilitators focused on introducing the nature of CRCI.  A short video clip was presented 
to participants to facilitate a brief discussion of their own experience of CRCI.  The 
facilitators assisted in discussion and guided discovery through questioning to help 
participants recognize that even small incremental changes in any one area of functioning 
(e.g. behaviour) could have an effect on many or all other areas of their experience.  All 
participants were encouraged to present cognitive and daily life challenges experienced 
since BCSs completed their cancer treatment and identify their goals for completing the 
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CRP.  There was only one teaching/practice module during this session and was 
presented to both the BCSs and training partners.  Tips and techniques to communicate 
clearly and assertively with others were reviewed (see Figure 2).  In the practice module, 
everyday scenarios were given to participants (e.g., job situation, physician’s office) and 
participants were instructed to practice giving assertive responses to one another.  
Homework was assigned at the end of the session.  
 
 
Figure 2. PowerPoint slide introducing strategies for improving communication. 
 
 Session two.  After agenda setting, the facilitators and participants reviewed and 
discussed previously assigned homework.  If problems arose, they were discussed briefly.  
This session consisted of two teaching/practice modules.  The session was presented 
together for the BCSs and training partners.  Cancer-related fatigue is one of the highest 
self-reported symptoms in cancer patients and survivors.  For ongoing sleep difficulty, 
the most effective treatment is to alter sleep habits.  The purpose of this session was 1) to 
discuss sleep hygiene and to learn and practice strategies that would help improve quality 
of sleep, and 2) to explore simple relaxation techniques to improve health and reduce 
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stress.  The facilitator taught methods for promoting relaxation to self-regulate arousal 
and reduce cancer-related distress, including various forms of mindfulness and 
meditation.  Practice exercises were 1) using the breath to create cognitive awareness and 
focus and 2) the raisin exercise and progressive muscle relaxation to facilitate 
mindfulness stress reduction.  Homework exercises were to practice deep breathing, 
progressive muscle relaxation, and to monitor relaxation levels by keeping a weekly 
relaxation diary (see Figure 3).   
 
 
Figure 3. Homework handout for week 2 – Monitoring Your Relaxation Level. 
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 Session three.  Agenda setting and review of homework occurred.  This session 
consisted of three teaching/practice modules.  The BCSs and training partners were 
separated into different rooms after the first teaching component of the session.  All 
participants regrouped for the combined teaching/practice module.  Attention difficulties 
are a major complaint associated with CRCI and has direct effects on other cognitive 
functions.  The purpose of this session was to define attention and its subtypes.  Elements 
of selective attention were taught and participants learnt strategies to overcome 
difficulties with selective attention.  The exercises involved visual searches for letters in a 
letter array (letter find), and counting the number of words (i.e. “of” “the” “and”) 
increasing in difficulty in different story passages.  Training partners discussed healthy, 
adaptive and appropriate ways of responding to internal and external triggers (see Figure 
4).   
 
 
Figure 4. PowerPoint slides from week 3 - Training Partner Session. 
 
A modified version of the Seashore Rhythms Test (Reitan & Wolfson, 1985) was 
developed and presented to participants for the combined exercise.  Complex musical 
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patterns increasing in difficulty were given in an auditory presentation over three trials 
consisting of 10, 15 and 30 musical pairs.  Participants had to indicate whether the pairs 
sounded the same or different.  The combined exercise was designed to facilitate 
discussion about the differences between auditory memory and attentional abilities.  
Homework included completing two “I Spy” activities, and having a conversation in a 
distracted environment (while watching television).  Partners were to review the 
MESSAGE strategy handout for supportive effective communication (adapted from 
Smith, Broughton et al., 2011).   
Session four.  Session four followed the usual format and focussed on helping the 
participants to understand the prerequisites for attention: arousal and alertness.  Sustained 
attention is the ability to maintain attention to sensory events for prolonged period of 
time.  Sustained attention is an important cognitive domain that is crucial to daily 
functioning, and can have a substantial impact on numerous other areas of cognitive 
functioning.  The facilitators discussed elements of sustained attention and barriers that 
impede concentration (see Figure 5). 
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Figure 5. PowerPoint slide from week 4 - Survivor Teaching Session. 
 
In the first practice activity, BCSs performed a computerized task of sustained visual 
attention.  Participants were instructed to watch a clock and tick on a piece of paper when 
it skipped a beat.  The second activity required listening to 60-second podcasts and 
providing synopses of the information heard.  The 60-second synopses provided an 
approach to practicing concentration and comprehension of spoken information.  The 
purpose of the training partner module was to review the MESSAGE handout, with 
particular emphasis on encouraging and engaging communication.  Strategies to reinforce 
their partner’s progress throughout the program and beyond were also discussed (see 
Figure 6). 
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Figure 6. PowerPoint slide from partner session week 4 – Teaching Reinforcement.  
 
The combined module provided teaching about reinforcing attention.  The practice 
activity involved the training partners to read an article to the survivors.  The survivors 
were instructed to capture important issues and recite as much of the story as possible to 
their training partner.  The training partners provided cued recall questions if salient 
points were missed.  The homework assigned to the BCSs included reading and the 
summarizing an article without any assistance.  Training partners were assigned to 
observe a mistake in their partner’s daily or weekly routine.  Their homework assignment 
involved not taking any action on correcting the mistake.  The mistake was discussed 
during the next training partner session.  The combined homework activity involved 
reading and/or listening to an article in a distracting environment.  Each person could be 
either the reader or the listener.  The listener was to summarize the article to their partner 
and the reader was to provide them with reinforcement.   
 Session five.  Session five followed the established pattern: agenda setting, 
homework review, discussion of the session topics and homework assignment.  The 
purpose of this session was to understand the difference between divided and alternating 
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attention (see Figure 7).  In the practice sessions, BCSs performed exercises that required 
them to 1) alphabetically alternate between boy and girl names (see Figure 8), 2) perform 
mental mathematical operations  and 3) perform alternating actions on a set of embedded 
words (e.g., circle “stripy” words – wasp or barcode , underline “sticky” words – glue or 
toffee) while ignoring irrelevant words.  The partner homework from session 4 
(observing a mistake) was reviewed and provided an introduction to discussing strategies 
to help with divided attention. 
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Figure 7. PowerPoint slide from breast cancer survivor session week 5– Defining 
Divided vs Alternating Attention. 
 
The combined practices were alphabetical N-back activities.  The N-back 
activities require temporary storage, and training might increase short-term storage 
capacity in either the verbal or the spatial domain (Lilienthal, Tamez, Talley, Shelton, 
Myerson, & Hale, 2013).  In the first activity, participants thought of the name of a food 
beginning with the next letter of the alphabet and were to name the previous person’s 
food (e.g. Person 1 would say “apple”, Person 2 would say “apple, banana” and so forth).  
In the second activity, the category was changed to animals.  Each person was instructed 
to say the name of an animal and the response from two people back (Person 1 would say 
“ant”, Person 2 would say “bear”, Person 3 would say “ant, cat” and so forth). 
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Figure 8. PowerPoint slide from breast cancer survivor session – Alternating Name 
Practice Activity  
 
Session six.  Session six followed the established pattern: agenda setting, 
homework review, discussion of the session topics and homework assignment.  The 
purpose of this session was to provide a brief overview of three main areas of self-
regulation (self-awareness/self-monitoring, impulse control/inhibition and emotional 
control/frustration tolerance) and to learn how to anticipate emotional triggers.  
Participants were taught healthy, pro-active ways to be successful in regulating their own 
physical, emotional and cognitive processes.  The training partner session started with the 
weekly review of successes and difficulties (see Figure 9).  Strategies to help training 
partners cope with impulsivity and managing anger were discussed.  The combined 
teaching/practice module focused on emotional control and anger triggers.  One of the 
practice activities instructed the BCSs to identify a recent situation where they became 
frustrated.  The training partners facilitated a discussion about possible strategies and 
solutions that could help their partners in the future.  Homework was assigned at the end 
of the session. 
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Figure 9. PowerPoint slide from training partner session 6 – Weekly Successes and 
Difficulties. 
 
 Session seven.  Session seven followed the established pattern and focused on the 
processes used to set goals and how to develop action plans.  The main theme for this 
session was goal-setting, planning (reasoning) and organization.  Participants were taught 
the S.M.A.R.T. (Specific, Measurable, Attainable, Reliable, and Timely) goal criteria to 
ensure that the goals created were within reason and attainable.  Practice exercises for the 
BCSs included chunking and categorization in order to retain longer sets of information.  
The training partners discussed unrealistic goal setting and ways to help their partner and 
themselves achieve S.M.A.R.T. goals.  The session did not have a combined teaching 
module.  The combined practice included activities of reasoning and problem-solving.  
Homework assigned to the BCSs was to develop actions plans.  An example of a plan 
would be to write at least ten steps required to complete a task, such as putting up a shelf 
in the kitchen. Another homework assignment required the development of short- and 
long-term goals including obstacles and possible solutions (see Figure 10).  
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Figure 10. Homework sample from session 7 – Developing Goals. 
 
 Session eight and nine.  Both sessions followed the established pattern of agenda 
setting, homework review, discussion of the session topics and homework assignment.  
The purpose of sessions eight and nine was to teach the strategies of goal management 
training; that is to improve an individual's ability to complete everyday tasks.  The goals 
of these sessions were for participants to 1) identify and evaluate daily life difficulties, 2) 
review problem solving strategies and action planning, and 3) learn how to manage 
conflicts more effectively.    
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Session ten.  After agenda setting, the facilitators and participants reviewed and 
discussed previously assigned homework.  Session ten was a review of the program 
content and discussion of future steps beyond the program.  
  
Analyses  
Feasibility and acceptability.  One of the evaluation goals was to provide 
demonstrated evidence of the feasibility and acceptability of the CRP.  Another goal was 
to determine methods to improve the program in the future,  
Recruitment and retention.  Recruitment took place at tertiary cancer site.  
Documentation included methods for referral, a log of participant inquiry, and strategies 
to increase participant enrolment.  A retention log was developed to record if participants 
left the study and included the date and reasons for leaving.  
Attendance rate.  An attendance log was maintained at each CRP session and 
assessment.  Documentation included the number of sessions and assessments attended 
for each participant and reasons for absence.  
Homework compliance.  BCSs and training partners completed a weekly 
evaluation form about their homework.  At each check-in, the homework evaluation form 
was discussed.  All participants were asked the following questions: 
1. What did we talk about last session that was important? 
2. What do you foresee getting in the way of completing your homework? 
3. What homework did you do? (If you didn’t do it, what got in the way?) 
4. What did you learn? 
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5. What happened (positive and negative) this week that the facilitators 
should know? 
6. What important issue do you want to bring up during check-in? 
Directly after the end of the program, BCSs were asked:  
7. How often did you complete your homework? 
Homework compliance was assessed based on the responses from questions 3, and 7 
noted above. 
Program evaluation.  Information about the acceptability of the CRP was 
obtained from BCS and training partners.  A Session Satisfaction Questionnaire was 
distributed weekly to all participants for feedback on the modules.  Participants were 
asked to rate the following questions on a five-point Likert scale (strongly disagree to 
strongly agree): 
1. The session objectives were clear to me. 
2. The session activities stimulated my learning. 
3. The activities in this session gave me sufficient practice and feedback. 
4. The difficulty level of this session was appropriate. 
5. The pace of this session was appropriate. 
6. The handouts provided were useful. 
7. The instructors were well prepared. 
8. The instructors were helpful. 
9. Please rate the overall quality of the session (excellent, very good, good, 
fair or poor).  
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Qualitative questions included: 
10. Things I liked about this sessions. 
11. Things I would change about this session. 
12. Additional information I would like on this topic. 
13. Additional comments. 
At the end of the CRP, two different versions of a Cognitive Rehabilitation 
Program Satisfaction Questionnaire were given to BCSs and training partners 
respectively, regarding their experiences with the program: All participants were asked 
the following questions: 
1. The program objectives were clear to me. 
2. The program activities stimulated my learning. 
3. The activities in this program gave me sufficient practice and feedback. 
4. The difficulty level of this program was appropriate. 
5. The length of this program appropriate. 
6. The handouts provided were useful. 
7. The presentations had enough information. 
8. The instructor (lead facilitator) was well prepared. 
9. The instructor (lead facilitator) was helpful. 
10. Overall quality of the session. 
11. Did you receive the kind of service you expected? 
12. To what extent has our program met your needs? 
13. How satisfied are you with the quality of help you received during the 
program? 
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14. How satisfied are you with the amount of help you received during the 
program? 
15. Has the program helped you to deal more effectively with you and/or your 
partner's difficulties? 
16. Overall, if a friend were in need of similar help, would you recommend 
our program to him or her? 
17. Overall, how satisfied are you with the CRP? 
Qualitative questions included: 
18. Things I liked about this program. 
19. Things I would change about this program. 
20. What changes if any have you noticed in yourself since the CRP program 
started. 
21. What changes if any have you noticed in your partner since the CRP 
program started? 
22. Can you sum up what have you found helpful about the program for you? 
23. Can you sum up what have you found helpful about the program for your 
partner? 
Additional questions asked specifically to BCSs included: 
1. How often did you practice the activities (beyond the completion of 
homework)? 
2. Do you feel you are more informed about the cognitive changes you 
experienced following chemotherapy? 
3. Compared to how I felt before beginning this study, now I am. 
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4. How do you rate your current quality of life? 
5. What were the strengths of the breast cancer survivor group? 
6. What were the weaknesses of the breast cancer survivor group? 
7. What topics should be more discussed within the breast cancer survivor 
group? 
8. What topics should be more reduced within the breast cancer survivor 
group? 
Questions to training partners about the program included:  
1. The instructors for the caregiver group were well prepared. 
2. The instructors for the caregiver group were helpful. 
3. What were the strengths of the caregiver group? 
4. What were the weaknesses of the caregiver group? 
5. What topics should be more discussed within the caregiver group? 
6. What topics should be more reduced within the caregiver group? 
 
Statistical analyses.  Descriptive statistics were used to summarize demographic 
variables, neuropsychological functioning and cancer characteristics.  Published 
normative data adjusted for age, education and gender where appropriate were used to 
convert participants raw cognitive test scores into standardized scores (z-scores; mean 
[M] = 0, standard deviation [SD] = 1; T-scores; M = 50, SD = 10).  Scores were adjusted 
for sign according to performance direction (with higher values indicating better 
performance for all variables.   
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 The study had a within-group, repeated measures design that allowed for 
significant effects to be measured despite low sample size.  One-way repeated measures 
ANOVAs with the within-subjects factor “time” (baseline, post-intervention and 
maintenance) were conducted for each of the neuropsychological measures.  Degrees of 
freedom were adjusted via the Greenhouse-Geisser method.  Post-hoc pairwise 
comparisons were calculated using the Bonferroni correction to evaluate whether 
differences in outcome scores for the different times of measurement were significant.  
Statistical analyses were performed with the Statistical Package for Social Sciences 
(version 19.0) with an alpha level set at .05 for all analyses.  Estimates of effect size were 
reported using partial eta squared.  These estimates were defined as small (η2 = 0.01), 
medium (η2 = 0.06), and large (η2 = 0.15) effects (Cohen, 1988). 
Reliable change indices.  The reliable change analysis allows the researcher or 
clinician to reduce the adverse impact of measurement error on test interpretation on an 
individual’s score and to determine if a change in the score is due to real change or 
chance variation.  In other words, is the difference in score clinically meaningful or due 
to random error.  Tests with published test-retest reliability possess inherent error; 
therefore, the RCI allows identification of changes in test scores that are clinically and 
statistically meaningful for each patient.  The RCI represented the 90% confidence 
interval for the difference in performance between two evaluations that would be 
expected if no real change occurred.  Importantly, the level of analysis for the RCI 
encompassed each individual patient, not the group as a whole.  Reliable change 
estimates were derived from a modification of the method proposed by Jacobson and 
Truax (1991).  
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The reliable change methodology allows the clinician to estimate measurement 
error surrounding test-retest difference scores.  Specifically, the standard error of 
difference (Sdiff) is used to create a confidence interval for the baseline-retest difference 
score.  The steps for calculating the Sdiff are provided below.  Note that the test-retest 
reliability coefficient is used in these formulae to make them more relevant to the 
interpretation of change over time.  Most researchers and test publishers use internal 
consistency reliability coefficients in their SEM formulas; internal consistency reliability 
is almost always higher than test-retest, making the SEM smaller.  In this study, RCI was 
computed by dividing the difference between pre-treatment and post-treatment scores by 
the standard error of measurement (RCI = [post-test – pretest] / SEmeas).  SEmeas = SD* (1-
r) 1/2 where SD = standard deviation of pretest and r = the reliability (test-retest 
reliability) of measure.  The difference was categorized as “reliable increase” (RCI > 
+1.64), “uncertain change” (-1.64 ≤ RCI ≤ +1.64) and “reliable decrease” (RCI < -1.64).  
In the present study, test-retest reliability and SDs for each test score were derived from 
published data—typically from information provided in the test manual. 
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Chapter 4: Results 
Demographics/Clinical Characteristics 
Demographic data and clinical characteristics for the six BCS and the six training 
partners are provided in Table 3.  All BCS were female with a mean age of 52.3 years 
(standard deviation [SD] = 7.0, range 43-59).  All BCS underwent surgery pre-
chemotherapy and received local radiation therapy (5000cGy, 25 fractions).  Four of the 
training partners were spouses and the remaining two were adult children.  The mean age 
of the training partners was 48.0 years of age (SD = 14.7, range 30-67). 
One BCS had a recurrence of cancer at the time of the first follow-up assessment.  
In addition, her training partner did not attend the last three sessions of the CRP due to 
work commitments and was unable to complete the first follow-up assessment 
questionnaires.  A second BCS had ongoing chronic pain, and related health concerns 
that could have impacted the results of her neuropsychological assessments.  In addition, 
there was a protocol deviation in the standardization of the neuropsychological battery 
with this participant in that the incorrect alternate form of the Brief Visuospatial Memory 
Test-Revised (BVMT-R) was administered on the second follow-up assessment.  The 
correct alternate form was administered at the end of the assessment and the Wechsler 
Adult Intelligence Scale-Third Edition (WAIS-III) Vocabulary subtest was administered 
during the delay.  Additionally, one BCS was seen for clinical purposes one year prior to 
the beginning of this study.  The alternate forms used were not the same alternate forms 
used for the other participants (i.e. this participant was administered HVLT-R Forms 2,4 
and 3, while the other participants were administered  HVLT-R Forms 1, 2 and 4).  
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Table 3. Demographic and Clinical Characteristics of Participant 
 
Breast Cancer Survivors  
 Mean SD Range 
Age at baseline (years) 52.3 7.0 43 - 59 
Education (years) 15.7 3.9 12 - 23 
Estimated FSIQ (baseline) 107.5 5.9 100 - 115 
Months between last chemotherapy treatment and 
baseline testing 71.5 73.6 12 - 212 
Training partners 
Age at baseline (years) 48.0 14.7 30 - 67 
Years of Education  15.2 1.1 12 - 20 
Relationships to  4 spouses; 2 children 
Cancer Characteristics 
 N   
Type of Cancer    
 Infiltrating Duct Carcinoma, Nos 3   
 Carcinoma, Nos 1   
 Infiltrating Duct And Lobular Carcinoma 1   
 Infiltrating Duct Mixed With Other Types 1   
Stage of Disease    
  II 2   
  III 2   
  Unknown 2   
Type of chemotherapy     
  FEC-D x 6 cycles 2   
  ACT x 4 cycles 1   
  AC  x 4 cycles 1   
  CMF x 6 cycles 1   
  ZOL x 10 cycles 1   
Surgery 6   
Hormonal Therapy 2   
Local Radiation (5000cGy, 25 fractions) 6   
Estrogen Receptor - Positive 4   
Progesterone Receptor - Positive 5   
Menopausal Status    
  Pre-menopausal 2   
  Post-menopausal 4   
Note. AC = Adriamycin, Cytoxan; ACT = Adriamycin, Cytoxan, Taxol; CMF = 
Cyclophosphamide IV or PO, methotrexate, fluorouracil; FEC-D = 5-fluorouracil–
epirubicin–cyclophosphamide followed by docetaxel; SD = Standard Deviation; ZOL= 
Zoledronic Acid  
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Aim 1: Feasibility and Acceptability 
Recruitment and retention.   Oncologists were emailed about the study 
objectives and a meeting was requested to discuss whether patients could be referred to 
the study from their clinic.  One oncologist responded to a request for a meeting and 
indicated that their current patient population did not meet the inclusion criteria.  Several 
health care professionals were also contacted and asked to post posters in clinic areas 
and/or mention to support group meetings in hopes of reaching a wider audience.  
Recruitment for the study lasted 4 months. Posters were displayed in the cancer site 
patient library, patient education bulletin boards in the site and clinic waiting rooms.  
Posters were sent to the Editorial Committee of the Breast North Info website, promoted 
at the local Run for the Cure and to facilitators of a breast cancer support group.  
Recruitment efforts were unsuccessful after 2 months, and as such a more intensive 
recruitment regimen initiated.  A brief article appeared in a local newspaper discussing 
the study.  The study was mentioned during a radio interview with the principal 
investigator, and individuals were referred from the neuropsychology clinic of the cancer 
site.  Three individuals did inquire about the study, one via telephone and two via email.  
After the study was explained, two of the three individuals did not meet the initial 
screening criteria.  Although recruitment efforts were slow, six breast cancer survivors 
(BCS) and their training partners were recruited.  
Baseline assessments took place within a 2-month period.  Each baseline 
assessment was scored within 48 hours and results were discussed with the 
neuropsychologist to determine the presence of neuropsychological impairment.  
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Participants were notified by telephone of their results and asked if they were interested 
in participating in the study.   
The cognitive rehabilitation program (CRP) was delivered to participants in the 
winter.  Six BCS and their training partners enrolled in the CRP study.  Another element 
of feasibility for any intervention research protocol is that of attrition.  Once recruited, are 
participants compliant in completing the protocol?  All the participants who entered into 
this pilot study completed.  This represents a 0% attrition rate or conversely, a 100% 
retention rate.   
Attendance.  The overall attendance rate for participants was high at 93% (BCS = 
94% and training partners = 92.5%).  Fifty-eight percent (n=7) of the participants 
attended all sessions, three participants missed one session (one BCS and two training 
partners), and two participants missed two sessions (one BCS and one training partner).  
Participants who missed sessions worked through the manual and received briefings from 
the facilitators. 
Homework compliance.  BCSs and training partner completed a weekly 
evaluation form about their homework.  At each check-in, the homework evaluation form 
was discussed.  Weekly, participants were asked “what homework did I do? (If I didn’t 
do it, what go in the way?)”  Qualitative responses indicated that for session 1, most 
participants reported they completed all the homework.  One BCS commented that she 
and her partner had discussions every night at supper while another stated she practiced 
trying to be assertive instead of aggressive when speaking to her spouse.  For session 2, 
participants reported they practiced the 10-count most often.  For sessions 3 through 7 the 
majority of participants indicated they completed all assigned homework.  For sessions 8 
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and 9, participants reported completing fewer activities.  Participants reported reasons for 
not completing homework were feeling overwhelmed, stressed, tired, lacking motivation 
and having other personal commitments. 
Directly after the end of the program, BCSs were asked how often they did the 
homework assigned to them by the facilitators.  Five of the participants reported they 
always completed their homework (all of it, at every session).  BCSs were also asked 
how often they practiced the activities (beyond the completion of homework).  Half of 
the BCSs indicated sometimes, two BCSs indicated often and 1 BCSs reported always.   
 
Program evaluation. 
Weekly Session Questionnaire.  All participants were encouraged to complete the 
session questionnaire despite their absence if they were away for a particular session to 
allow for feedback of the materials presented.  Positive results (strongly agreed/agreed 
and excellent/very good) for each of the questions are presented in Table 4.  
Clarity of session objectives.  The majority of the participants “strongly agreed” 
or “agreed” the session objectives were clear to them for each of the weekly sessions 
(range 75% - 100%).  For sessions 5 and 9 respectively, 2 participants (1 BCSs and 1 
training partner in each session) rated the objectives as not appropriate or not applicable. 
Three participants (1 BCS and 2 training partners) rated session 7 objectives as not 
appropriate or not applicable.  
Activities stimulated learning.  The majority of the participants “strongly agreed” 
or “agreed” the session activities stimulated their learning for each of the weekly sessions 
(range 75% - 100%).  For session 1, a BCS indicated they “neither agreed or nor 
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disagreed” that session activities stimulated their learning.  For session 5, 1 training 
partner indicated they “disagreed” and 2 participants (1 BCS and 1 training partner) rated 
the question as not appropriate or not applicable.  For session 7, three participants (1 BCS 
and 2 training partners) rated the question as not appropriate or not applicable  
Activities provided sufficient feedback.  On most sessions, participants indicated 
they “strongly agreed” or “agreed” the activities gave them sufficient practice and 
feedback (range 58%-92%).  Specifically on session 8, four participants (3 BCSs and 1 
training partner) rated that they “neither agreed nor disagreed”.  One BCS remarked that 
relaxation and breathing awareness (session 2) was an area of concern and was looking 
forward to implementing what was learned in class to reach “a positive outcome”.  
Difficulty level of session.  The majority of the participants “strongly agreed” or 
“agreed” the session activities stimulated their learning for each of the weekly sessions 
(range 75% - 100%).  Two participants (1 BCS and 1 training partners) rated they 
“neither agreed or nor disagreed” the difficulty level was appropriate for session 2.  For 
session 7, three participants (1 BCS and 2 training partners) rated the question as not 
appropriate or not applicable. 
Pace of session.  Across all sessions, most participants “strongly agreed” or 
“agreed” the pace of the sessions were appropriate (range 75% - 100%).  For session 7, 
three participants (1 BCS and 2 training partners) rated the question as not appropriate or 
not applicable.  For session 8, one training partner “disagreed, one BCS rated they 
“neither agreed nor disagreed” and one training partner rated the question as not 
appropriate or not applicable  In addition, participants indicated session 8 felt rushed and 
too much information was presented.  
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Usefulness of handouts.  The majority of the participants “strongly agreed” or 
“agreed” the handouts provided were useful for each of the sessions (range 75% - 100%).   
For session 7, 3 participants (1 BCS and 2 training partners) rated the question as not 
appropriate or not applicable.  Participants commented that they found the handouts very 
useful and would like to know where to access additional activities  
Preparedness of instructors.  Across all sessions, most participants “strongly 
agreed” or “agreed” the preparedness of the sessions were appropriate (range 75% - 
100%).  For session 7, three participants (1 BCS and 2 training partners) rated the 
question as not appropriate or not applicable.  Participants provided feedback about areas 
to improve which included reviewing grammar, producing better audio quality of 
recordings and hole-punching their handouts for their binders.  
Helpfulness of instructors.  Across all sessions, most participants “strongly 
agreed” or “agreed” the helpfulness of the sessions were appropriate (range 75% - 100%).  
For session 7, three participants (1 BCS and 2 training partners) rated the question as not 
appropriate or not applicable. 
Overall quality of session.  Across all sessions, most participants rated the overall 
quality of the sessions as “excellent” or “very good” (range 73 - 100%).  Most sessions 
had a rating of 91% or 100% with the exception of session 8.  For session 8, three 
participants (2 BCSs and 1 training partner) rated the overall quality as “good”.  
Participants indicated they thoroughly enjoyed the review session and activities (session 
10) and “felt it was a good wrap up to the classes.  
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Table 4. Positive results (strongly agreed/agreed and excellent/very good) for Weekly Session Questionnaire for all sessions 
 
  
Session 1 Session 2 Session 3 Session 4 Session 5 Session 6 Session 7 
Sessions 8 
& 9 Session 10 
  n % n % n % n % n % n % n % n % n % 
The session objectives 
were clear to me. 
12 100 12 100 11 92 11 92 10 83 11 92 9 75 11 92 10 83 
The session activities 
stimulated my learning. 
11 92 12 100 11 92 12 100 9 75 11 92 9 75 10 83 10 83 
The activities in this 
session gave me 
sufficient practice and 
feedback. 
10 83 11 92 10 83 11 92 9 75 11 92 9 75 7 58 10 83 
The difficulty level of 
this session was 
appropriate. 
12 100 10 83 11 92 11 92 9 75 11 92 9 75 10 83 10 83 
The pace of this session 
was appropriate. 
12 100 12 100 10 83 11 92 10 83 11 92 9 75 9 75 10 83 
The handouts provided 
were useful. 
12 100 12 100 11 92 12 100 10 83 11 92 9 75 11 92 10 83 
The instructors were well 
prepared 
12 100 11 92 11 92 12 100 10 83 10 83 9 75 11 92 10 83 
The instructors were 
helpful 
12 100 12 100 11 92 12 100 10 83 11 92 9 75 11 92 10 83 
Overall quality of the 
session
a
 
10 83 11 92 11 92 12 100 9 75 10 83 9 75 8 67 10 83 
a– Response options included “excellent” or “very good” 
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Cognitive Rehabilitation Program Satisfaction Questionnaire.  Measures of 
acceptability of the CRP were at a 100% positive response rate for the majority of the 
questions on the program satisfaction questions (see Figure 11).   
The majority of the participants, “strongly agreed” or “agreed” the session 
objectives were clear to them for each of the weekly sessions.  All of the participants 
“strongly agreed” or “agreed” the program activities stimulated learning and 100% 
indicated the difficulty level of the program was appropriate.  Ninety-two percent (n=11) 
felt the program contents (handouts and presentations) were useful.  One participant 
remarked “I liked the presentations that were followed by the practical exercises”.  Nine 
participants (5 BCSs and 4 training partners) “strongly agreed” or “agreed” the activities 
provided sufficient practice and feedback.  Two training partners endorsed a neutral 
response and 1 BCS disagreed.  Sixty- six percent (4/6) of the BCSs thought the length of 
the program was appropriate; one participant was neutral and the other participant did not 
agree.  All the training partners “strongly agreed” or “agreed” the program length was 
appropriate.  Participants included comments such as “sometimes sessions felt rushed, 
would maybe lengthen the number of weeks to ensure ample time to explore all 
activities”.  Furthermore, all of the participants “strongly agreed” or “agreed” that the 
lead facilitator (the principal investigator) was well prepared and helpful throughout the 
CRP.  
Overall, ninety-two percent (n=11) rated the overall quality of the program as 
“excellent” or “very good.  All of the participants (n=12) were “very satisfied” or 
“satisfied” with the program and would recommend the treatment to a friend (“Yes, 
definitely” or “Yes, generally”).  Participants included comments such as: 
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“The program covered a range of the problems we were experiencing and gave us 
proactive solutions when they occurred BUT also provided awareness strategies 
to recognize the beginning of a situation and prevent it before it happened”. - 
Breast Cancer Survivor 
“The caregiver group was very comforting and reassuring.  It was a support group 
for us to release our frustrations and build ourselves up to help our partners”. - 
Training partner 
“I found it [the program] inspired and refreshed me in my ongoing support 
through my partner's rehabilitation”. - Training partner 
“It [the training partner group] was supportive.  There was no competition - 
everyone was there for the same reasons and looking for the best solution for their 
loved one.  I found it inspired and refreshed me in my ongoing support through 
my partner's rehabilitation”. - Training partner 
All of the participants (n=12) indicated the program helped them deal more effectively 
with themselves or their partner’s difficulties (“very satisfied” or “satisfied”), 
“It was relevant [the program].  Immediately we could begin using the strategies 
this program covered”. – Breast Cancer Survivor. 
“It was interesting to hear solutions and problems of other people in the same or 
similar situation” - Training partner 
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Figure 11. Program satisfaction results - ratings (agree and strongly agree) 
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Participants were asked what enjoyed most and least about the CRP.  In answer to the 
question concerning the best features, the common themes reported were the a) 
information and activities provided; b) group dynamics and c) inclusion of a partner 
group.  One participant said [they] “loved the concept; Love believing we can regain 
some of what was lost”.  When asked what the weaknesses of the CRP were, participants 
stated a) time of year; b) length of sessions; and c) the amount of homework.  Participants 
indicated the time of the year was not optimal due to weather conditions (program was 
offered in winter); have an earlier start time (6:00pm instead of 6:30pm) and/or offer 
classes during the day as well.  After completion of the program participants also agreed 
it would be better not to condense two sessions into one; 
“Not to put the classes together; there was so much information just for one 
session”, and 
“Understanding we had to condense a couple of sessions - we found we were so 
focused on the homework, we did not have time to fully absorb it and apply it to 
our everyday lives.” 
 
Questions addressed specifically to BCSs: 
Practicing activities.  The BCS responses were variable when asked how often 
they practiced the activities beyond the completion of homework.  Three BCSs (50%) 
reported sometimes, two reported often (33%) and one BCS (17%) indicated always.   
Feeling informed about cognitive changes.  All of the BCS (n=6) reported they 
felt more informed about the cognitive changes they experienced following 
chemotherapy.  Two BCSs indicated they felt the information was too generalized and 
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would have liked a discussion about each individual’s cognitive issues and experiences 
following cancer treatment.  
Subjective ratings of improvement and quality of life.  Four of the BCSs reported 
they felt “much improved” compared to how they felt before beginning this study and 
five BCS rated their current quality of life as somewhat better. 
Strengths and weaknesses of BCS group.  Most of the BCSs indicated they felt the 
program had no weakness. One participant indicated: 
“participants should have expressed exactly what problems they were 
experiencing so that we could determine if we all had the same thing (problem) in 
common”. 
BCSs stated they enjoyed the camaraderie, openness, positive attitudes and “willingness 
to stay in the study”. 
Additional topics for discussion.  BCSs indicated they would like more discussion 
on each BCS’s experience and coping mechanisms, more in-depth teaching module for 
memory/concentration, and differences between CRCI and dementia.  
 
Questions addressed specifically to training partners: 
Preparedness and helpfulness of instructors for caregiver group.  All of the 
training partners “strongly agreed” or “agreed” the instructors (Social Worker and 
graduate student) were well prepared and helpful throughout the CRP 
Strengths and weaknesses of caregiver group.  The training partners did not report 
many weaknesses.  Two training partner felt the information presented was repetitive and 
another felt the length of the caregiver sessions was long enough to allow for discussion 
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on a meaningful topic.  Training partner’s comments about the strengths of the caregiver 
group are outlined below: 
“Every week [the instructors] had us talk about our [weekly] positive/negative 
experiences, which were beneficial in the sense that some of the experiences were 
similar”. 
“They allowed us to express our concerns about our partners and offered 
suggestions that were very helpful”.  
“Great alternative methods to approach situations”. 
“It was supportive. There was no competition - everyone was there for the same 
reasons and looking for the best solution for their loved one.  I found it inspired 
and refreshed me in my ongoing support through my partner's rehabilitation”. 
“Was able to be with others who were dealing with the same problems as me”. 
“Camaraderie; ability to learn from each other”. 
Additional topics for discussion.  Training partners indicated they would 
appreciate more discussion on each of the BCSs’ specific cognitive issues, additional 
compensatory strategies, and to incorporate ways younger children could be involved and 
exercises adults could do with them. 
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Aim 2: Improvement and Maintenance of Neuropsychological Outcome Measures 
Neuropsychological performance. All BCSs scored within the impaired range 
on at least one measure at baseline.  Areas of impairments were variable for the BCSs at 
baseline.  Impairments were most commonly seen on a test of verbal fluency (FAS), a 
test of list-learning and memory (Hopkins Verbal Learning Test-Revised, HVLT-R), a 
test of visuospatial- learning and memory (Benton Visuospatial Memory Test-Revised, 
BVMT-R), and a test of sustained attention (Connors’ Continuous Performance Test-II, 
CPT-2).  Based on BCSs’ demographics variables and their performance on a word 
recognition test insensitive to neuronal injury, BCSs had average pre-morbid intellectual 
ability (M = 107.50, SD = 5.86).  Descriptive statistics for the standardized 
neuropsychological measures for the BCSs are displayed in Table 5.  Means at baseline 
and follow-up assessments fell within the normative range across tests.  In general, the 
effect of time was not significant for most of the cognitive abilities measured.  Upward 
trends across time, although not statistically significant were observed on most of the 
neuropsychological measures.  
Attentional capacity/working memory.  In terms of attentional capacity, a 
repeated-measures ANOVA revealed a significant main effect for digit span (F (2,10) = 
3.91, p = 0.01, pƞ
2  
= .59).  Bonferroni post hoc test did not show (p > .05) the source of 
differences between the assessment times.  The first trial of the HVLT-R and BVMT-R 
can be utilized as measures of focused attention.  Repeated measures ANOVA for 
HVLT-R Trial 1 and BMVT-R Trial 1 were not significant for main effects (p’s >.05).  
Effect sizes across all measures ranged from 0.03 to 0.59. 
71 
 
Concentration/focused attention.  On a measure of inattentiveness (CPT-2: 
Omissions), a one-way repeated measures ANOVA revealed significant main effects for 
time (F (2, 10) = 4.224, p = 0.085, pƞ
2  
= .46).  Bonferroni post hoc test did not show (p 
> .05) the source of differences between the assessment times.  On a measure of 
impulsivity (CPT-2: Commissions), a one-way repeated measures ANOVA revealed a 
significant main effect for time (F (2, 10) = 6.357, p = 0.017, pƞ
2  
= .56).  Bonferroni post 
hoc test did not reveal (p > .05) the source of differences between the assessment times.  
The detectability (CPT-2: d’) provides information on how well the examinee 
discriminates between targets and non-targets.  A one-way repeated measures ANOVA 
revealed a significant main effect for time (F (2, 10) = 7.451, p = 0.01, pƞ
2  
= .60).  Post-
hoc analysis showed that there was a significant difference (p = .05) between post-
intervention scores (T1) and at maintenance (T2).  Effect sizes across all measures were 
large and ranged from 0.46 to 0.60. 
Sustained attention (vigilance). On measures of vigilance, one-way repeated 
measures ANOVA did not reveal a significant main effect for time (p’s >.05).  Effect 
sizes across all measures ranged from 0.06 to 0.33. 
Processing speed.  One-way repeated measures ANOVA did not reveal any 
significance main effects for time on measures of processing speed (p’s >.05).  Effect 
sizes across all measures ranged from 0.01 to 0.26. 
Executive functioning.  On a measure of cognitive flexibility, divided attention 
and perceptual motor functioning under time pressure (Trails Making B), a repeated 
measures ANOVA did not reveal a significant main effect for time (p >.05).  Similarly, 
one-way repeated measures ANOVAs did not reveal significant main effects for time (p’s 
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>.05) on measures of the WCST (total errors, preservative responses, preservative errors 
and conceptual level responses).  Effect sizes across all measures ranged from 0.10 to 
0.27. 
Motor functioning.  There were no statistically significant improvements with 
visuomotor- coordination, dexterity and hand strength in the BCSs’ dominant hand.  
Motor dexterity with the non-dominant hand indicated a significant main effect for time 
(F (2, 10) = 103.34, p = 0.01, pƞ
2  
= .59).  Bonferroni post hoc test did not reveal (p > .05) 
the source of differences between the assessment times.  However a difference between 
baseline and the 20-week follow-up assessment approached significance (p = 0.065).  
Hand strength with the non-dominant hand indicated a significant main effect for time (F 
(2, 10) = 6.364, p = 0.016, pƞ
2  
= .56).  Bonferroni post hoc test did not reveal (p > .05) 
the source of differences between the assessment times.  Effect sizes across all measures 
ranged from 0.25 to 0.59. 
Language.  One-way repeated measures ANOVA did not reveal any significant 
for main effects for time on measures of semantic and phonemic fluency (p’s >.05).  On a 
measure of confrontation naming (Boston Naming Test-2 [BNT-2]), a one-way repeated 
measures ANOVA revealed a significant main effect for time (F (2, 10) = 250.39, p = 
0.005, pƞ
2  
= .65).  Bonferroni post hoc test did not reveal (p > .05) the source of 
differences between the assessment times.  Effect sizes across all measures ranged from 0 
to 0.65. 
Memory: learning.  One-way repeated measures ANOVA did not reveal any 
significant main effects for time (p’s >.05) on measures of verbal (HVLT-R Total Recall) 
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and visuospatial learning (BVMT-R Total Recall).  Effect sizes for verbal learning was 
0.18 and visual memory was 0.27. 
Memory: recall/recognition.  One-way repeated measures ANOVA did not reveal 
any significant main effects for time (p’s >.05) on measures of verbal recall (HVLT-R 
Delayed Recall), retention discrimination (HVLT-R Recognition Discrimination Index), 
and visuospatial- recall (BVMT-R Delayed Recall).  Effect sizes were small ranging from 
0.02 to 0.03. 
Visuospatial Perception.  Raw scores on the JOLO were corrected for age and 
gender.  A one-way repeated measures ANOVA revealed a significant main effect for 
time (F (2, 10) = 5.0674, p = 0.030, pƞ
2  
= .50).  Bonferroni post hoc test did not show (p 
> .05) the source of differences between the assessment times.  Scores also indicated that 
at baseline, two participants scored within the average range, one participant scored 
within the high average range, and three participants scored in the superior range.  Post-
intervention scores indicated marked improvement in visuospatial perception (five of the 
participants had scores within the superior range) and at 20-weeks after intervention, all 
six participants had scores within the superior range.   
Reliable change indices.  Normative data were not available for the BNT-2 and 
JOLO test, and RCI were not calculated for these tests.  Reliable change indices are 
presented for all tests (see Table 6).  Examination of individual scores across this group 
revealed no change in most cognitive domains.  Three BCS showed reliable 
improvements on a  measures of working memory (Digit Span), from baseline to 
maintenance, processing speed (CPT-2 Hit Reaction time) post-intervention to 
maintenance and focused attention (CPT-2: Commissions) from baseline to maintenance.  
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Four BCSs showed worsening on measures of visuospatial learning (BVMT-R Total) 
from follow-up to maintenance and three BCSs worsened on a measure of visuospatial 
recall (BVMT-R Delayed Recall) from baseline to post-intervention.   
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Table 5. Mean (Z-scores) and Standard Deviations for Neuropsychological Tests Across Assessments 
 
Cognitive Domain 
Baseline 
Post-
Treatment 
Follow-up 
Treatment p Effect Size 
M SD M SD M SD 
Attentional Capacity/Working 
Memory       
  
   Digit Span: Total -0.11 0.98 0.83 1.01 0.94 1.18  .011 0.592 
   HVLT-R: Trial 1 -0.80 0.71 -0.25 0.86 -0.33 0.82 .484 0.135 
   BVMT-R: Trial 1 -0.35 1.05 0.03 0.88 -0.05 0.81 .665 0.078 
   LNS: Total  0.44 1.47 0.67 0.97 0.61 1.57 .860 0.030 
Concentration/Focused Attention         
   CPT-2: Omissions (Inattention)
a
 0.27 0.46 0.71 0.01 0.65 0.15 .047 0.458 
   CPT-2: Commissions 
(Impulsivity)
a
 -0.48 0.84 0.59 0.92 0.81 1.11 
.017 0.560 
   CPT2d (inattention)
a
 -0.33 0.90 0.88 1.16 1.58 1.35 .010 0.598 
Sustained Attention (Vigilance)         
   Hit RT Block Change
a
 -0.29 1.35 0.56 0.85 0.01 1.17 .135 0.330 
   Hit SE Block Change
a
 -0.39 0.40 0.28 0.91 -0.20 0.82 .350 0.189 
   Hit RT ISI Change
a
 0.32 0.99 0.15 0.78 0.15 0.52 .731 0.061 
Processing Speed         
  Coding  0.44 1.11 1.22 0.91 0.72 0.77 .219 0.262 
  Trail Making Test – A 0.73 1.03 1.03 0.89 1.17 0.99 .509 0.126 
  CPT-2: HitRT
a
 0.35 0.85 0.43 1.29 0.43 1.05 .955 0.009 
Executive Functioning         
  Trail Making Test – B -0.17 1.11 -0.03 0.94 0.15 0.79 .595 0.099 
  WCST:CV4:  Total Errors -0.72 1.00 -0.27 1.28 0.08 0.78 .277 0.227 
  WCST:CV4: Preservative 
Responses 
-0.67 1.05 
-0.35 1.35 0.27 0.77 
.224 0.259 
  WCST:CV4: Preservative Errors -0.60 1.02 -0.32 1.28 0.25 0.83 .263 0.234 
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Table 5 Continued         
Cognitive Domain 
Baseline 
Post-
Treatment 
Follow-up 
Treatment p Effect Size 
Mean SD Mean SD Mean SD 
  WCST:CV4: Conceptual Level 
Responses 
-0.77 0.88 -0.30 1.41 0.20 0.76 .201 0.274 
Motor Functioning         
  Grip Strength – Dominant -0.40 0.88 -0.73 0.95 -1.07 1.05 .065 0.421 
  Grip Strength – Non-dominant  -0.10 0.50 -0.68 0.73 -0.75 0.94 .016 0.560 
  Grooved Pegboard – Dominant  0.62 1.20 -0.03 1.00 0.65 1.03 .231 0.254 
  Grooved Pegboard – Non-
dominant 0.37 1.03 0.30 1.35 1.05 1.21 
.012 0.586 
Language         
   Verbal Fluency  -0.67 0.96 -0.62 0.67 -0.32 0.73 .222 0.260 
   Animals 0.58 0.65 0.60 0.61 0.62 1.12 .996 0.001 
   Boston Naming Test -0.45 0.71 0.50 0.50 0.78 0.89 .005 0.653 
Memory: Learning         
  HVLT-R: Total  -0.45 0.92 -0.03 0.62 0.05 0.72 .364 0.183 
  BVMT-R: Total  -0.62 1.07 0.08 0.87 -0.27 0.57 .194 0.279 
Memory: Recall/Recognition         
  HVLT-R:  Delayed Recall 0.07 0.83 0.08 0.87 0.23 0.50 .902 0.020 
  BVMT-R: Delayed Recall -0.18 1.08 -0.03 1.09 -0.22 0.59 .901 0.021 
  HVLT-R: RDI 0.07 0.14 0.18 0.88 -0.02 0.65 .859 0.030 
Visuospatial Perception         
  JOLO (corrected raw values) 27.67 2.80 29.17 0.75 30.00 0.89 .030 .503 
Note. CPT-2 = Connors Performance Test - 2; HVLT-R = Hopkins Verbal Learning Test-Revised; BVMT-R = Benton Visual 
Memory Test – Revised; LNS = Letter Number Sequencing; RDI – Recognition Discrimination Index; RT = Reaction Time; 
WCST = Wisconsin Card Sorting Test 
a 
Reversed scored so that for all variables higher means indicate better performance  
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Table 6. Individuals Evidencing Reliable Change Between Sessions  
 
Cognitive Domain 
T0 vs T1 T1 vs T2 T0 vs T2 
Worsen 
No 
Change 
Improve Worsen 
No 
Change 
Improve Worsen 
No 
Change 
Improve 
Attentional Capacity/Working 
Memory 
         
   Digit Span: Total 0 5 1 0 6 0 0 3 3 
   HVLT-R: Trial 1 0 4 0 1 5 0 0 6 0 
   LNS: Total  0 5 1 2 3 1 2 3 1 
Concentration/Focused Attention          
   CPT-2: Omissions (Inattention)
a
 0 6 0 0 6 0 0 6 0 
   CPT-2: Commissions 
(Impulsivity)
a
 
1 3 2 0 6 0 0 3 3 
   CPT2d (inattention)
a
 0 6 0 0 6 0 0 6 0 
Sustained Attention (Vigilance)          
   Hit RT Block Change
a
 0 6 0 0 6 0 0 6 0 
   Hit SE Block Change
a
 0 6 0 0 6 0 0 6 0 
   Hit RT ISI Change
a
 0 6 0 0 6 0 0 6 0 
Processing Speed          
  Coding  0 4 2 0 6 0 0 6 0 
  Trail Making Test – A 0 5 0 0 6 0 1 5 0 
  CPT-2: HitRT
 a
 0 6 0 2 1 3 0 4 2 
Executive Functioning          
  Trail Making Test - B 0 6 0 0 6 0 1 5 0 
  WCST:CV4: Total Errors 0 6 0 0 6 0 0 6 0 
  WCST:CV4:  Preservative 
Responses 
0 6 0 0 6 0 0 6 0 
  WCST:CV4:  Preservative Errors 0 6 0 0 6 0 0 6 0 
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Table 6 Continued           
Cognitive Domain 
T0 vs T1 T1 vs T2 T0 vs T2 
Worsen 
No 
Change 
Improve Worsen 
No 
Change 
Improve Worsen 
No 
Change 
Improve 
  WCST:CV4:  Conceptual Level 
Responses 
0 6 0 0 6 0 0 6 0 
Motor Functioning          
  Grip Strength – Dominant 0 6 0 0 6 0 0 6 0 
  Grip Strength – Non-dominant  0 6 0 0 6 0 0 6 0 
  Grooved Pegboard – Dominant  0 5 1 1 5 0 0 6 0 
  Grooved Pegboard – Non-dominant 0 6 0 0 6 0 0 6 0 
Language          
   Verbal Fluency  0 6 0 0 6 0 0 6 0 
   Animals 0 6 0 0 6 0 1 5 0 
   Boston Naming Test
b
 - - - - - - - - - 
Memory: Learning          
  HVLT-R: Total  0 6 0 0 6 0 1 5 0 
  BVMT-R: Total  0 6 0 4 2 0 2 3 1 
Memory: Recall/Recognition          
  HVLT-R: Delayed Recall 0 6 0 0 6 0 0 6 0 
  BVMT-R: Delayed Recall 3 2 1 1 5 0 2 3 1 
  HVLT-R: RDI 0 6 0 0 6 0 0 6 0 
Visuospatial Perception          
  JOLO
b
 - - - - - - - - - 
Note. CPT-2 = Connors Performance Test - 2; HVLT-R = Hopkins Verbal Learning Test-Revised; BVMT-R = Benton Visual 
Memory Test – Revised; LNS = Letter Number Sequencing; RDI – Recognition Discrimination Index; RT = Reaction Time; 
WCST = Wisconsin Card Sorting Test 
a
Reversed scored for all variables; higher means indicate better performance  
b
Unable to find data to calculate RCI
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Self-reported domains of functioning.  A one-way repeated measure ANOVA 
did not reveal a significant main effect for time on the Beck Depression Inventory-II 
(BDI-II).  However, mean BDI-II raw scores indicated there was a decline in self-
reported depressive symptoms from baseline (M = 15.17; SD=5.70) to T2 (M = 8.3; 
SD=5.53).  A one-way repeated measures ANOVA revealed a significant main effect for 
time on the Beck Anxiety Inventory (F (2, 2) = 5.632, p < .05,  pƞ
2
 = .53).  Bonferroni 
post hoc test did not show (p > .05) the source of differences between the assessment 
times.  There was a pattern of a decline in self-reported symptoms of anxiety across time.  
The global severity index (GSI) from the Brief-Symptom Inventory-18 indicated 
participants did not report distress and there no were significant main effects across 
testing times (p’s >.05) for the GSI and the three clinical subscales  
 Examination of the Working Memory subscale of the BRIEF-A Self-report 
revealed a significant main effect for time relating directly to the participants ability to 
sustain working memory (F(2,10) = 4.970, p > .05, pƞ
2 
= .49).  Bonferroni post hoc test 
did not show (p > .05) the source of differences between the assessment times.  The 
Metacognitive Index, a measure of the ability to actively problem solve in a variety of 
contexts, revealed a significant main effect for time (F (2, 6) = 6.43, p > .05, pƞ
2 
= .68) 
(see Table 7).  Bonferroni post hoc test did not show (p > .05) the source of differences 
between the assessment times.  No significant improvements were observed on the other 
self-report subscales or the indices.   
A repeated measures ANOVA determined that the mean total on the Perceived 
Deficit Score Questionnaire was not statistically significant between testing sessions but 
scores showed a trend in improvement for perceived cognitive functioning over time 
80 
 
(F(2,10)= 3.91, p = .06, pƞ
2 
= .44).  The greatest impairment in self-perceived cognition at 
baseline was observed in the attention/concentration and retrospective memory subscale 
scales.  All the PDQ subscales indicated improvement across time, although not 
statistically significant.  
A one-way repeated measures ANOVA did not reveal any significant main effects 
for time on a measure of overall quality of life (p >.05).  On a measure of subjective 
cognitive functioning, a one-way repeated measures ANVOA revealed a significant 
effect for time (F (2, 10) = 5.40, p > .05, pƞ
2 
= .51).  Bonferroni post hoc test did not show 
(p > .05) the source of differences between the assessment times.  Although not 
significant, mean scores indicated that the BCSs felt cognitive function improved 
between baseline and post-intervention.  This feeling was maintained 20-weeks later.  All 
other subscales of the EORTC did not reveal any significant main effects, p >.05. 
Caregiver measures. One training partner was not able to attend the post-
assessment (T1) due to work commitments.  Repeated measures analyses for the BRIEF-
A informant report and CQOLC included five training partners. 
On the BRIEF-A Informant report, a one-way repeated measures ANOVA 
revealed a significant main effect for time on the emotional control subscale (F(2,8) = 
25.877, p < 0.001, pƞ
2  
= .86).  Bonferroni post hoc test results revealed that the difference 
was between baseline and post intervention (p = 0.002) ¸ and between baseline and the 
20-week follow-up assessment (p = 0.03).  A one-way repeated measures ANOVA 
revealed significant main effects for time on the planning/organization subscale (F (2, 8) 
= 20.044, p < 0.001, pƞ
2  
= .83).  Bonferroni post hoc test results revealed that the 
difference was between baseline and post intervention (p = 0.011), and between baseline 
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and the 20-week follow-up assessment (p = 0.05).  A one-way repeated measures 
ANOVA revealed significant main effects for time on the behavioral regulation index (F 
(2, 8) = 9.492, p = 0.008, pƞ
2  
= .70).  Bonferroni post hoc test revealed the difference was 
between baseline and post intervention (p = 0.05).  A one-way repeated measures 
ANOVA revealed significant main effects for time on the metacognition index (F (2, 8) = 
4.654, p = 0.046, pƞ
2  
= .54).  Bonferroni post hoc test revealed that the difference was 
between baseline and post intervention (p = 0.05).  A one-way repeated measures 
ANOVA revealed significant main effects for time on the global executive composite 
index (F (2, 8) = 9.386, p = 0.008, pƞ
2  
= .70).  Bonferroni post hoc test revealed that the 
difference was between baseline and post intervention (p = 0.02). 
There were no significant changes in the total CQOLC score.  However, mean 
scores decreased across time indicating that training partners were reporting a better 
quality of life.  
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Table 7. Mean and Standard Deviations for Self-Reported Measures Across Assessments 
 
Subjective Measure 
Baseline 
Post-
Treatment 
Follow-up 
Treatment p 
Effect 
Size 
M SD M SD M SD 
BAI (raw scores) 12.17 7.8 6.17 4.5 4.17 2.3 .023 0.530 
BDI-II (raw scores) 15.17 5.7 10.00 4.1 8.33 5.55 .096 0.374 
BSI-18 (T-Score)
 a
         
  Somatization 47.17 8.5 49.83 9.7 51.00 9.4 .282 0.223 
  Depression 40.83 10.7 47.00 8.9 48.17 3.9 .129 0.336 
  Anxiety 48.17 11.3 52.83 9.5 52.83 9.5 .587 0.101 
  Global Severity Index 45.33 13.2 49.50 10.1 46.67 9.1 .351 0.189 
BRIEF-A Self Report (T-scores)
a 
Behavioral Regulation 
Index 
46.67 11.67 46.50 13.47 56.67 10.23 .556 0.111 
 Inhibit Subscale 53.50 2.59 50.50 9.61 49.67 7.60 .510 0.126 
 Shift Subscale 44.17 10.63 39.67 12.64 56.50 12.42 .141 0.324 
 Emotional Control 
Subscale 
39.83 13.38 46.50 12.33 62.67 10.07 .117 0.349 
 Self-Monitor Subscale 52.50 9.27 50.67 10.35 48.33 11.33 .857 0.030 
Metacognition Index 42.00 7.80 44.50 5.86 56.83 7.67 .032 0.499 
  Initiate Subscale 46.67 12.14 46.00 9.12 56.50 10.96 .556 0.440 
  Working Memory 
Subscale 
27.33 13.66 34.00 5.02 60.17 6.39 .032 0.499 
  Plan/Organize 
Subscale 
45.67 7.63 44.50 10.48 59.50 8.80 .271 0.230 
  Task Monitor 
Subscale 
46.83 6.91 45.33 2.58 53.50 6.38 .213 0.266 
  Organization of 
Materials Subscale 
53.50 6.57 55.67 7.01 49.83 7.47 .556 0.441 
Global Executive 
Composite 
43.50 8.87 45.17 8.28 57.00 8.02 .162 0.305 
Perceived Deficits Questionnaire (raw scores) 
Attention/Concentration 10.33 5.3 9.33 3.1 7.67 2.3 .223 0.259 
Prospective 
Retrospective Memory 
10.67 3.9 8.33 2.0 6.67 3.0 .065 0.484 
Memory 8.00 4.4 5.50 1.9 4.17 2.3 .029 0.509 
Planning/Organization 9.00 4.4 8.17 3.5 5.83 2.3 .084 0.391 
Total 38.00 16.5 31.33 8.6 24.33 6.4 .056 0.439 
EORTC QLQ C30         
 Global Health 
Status/Quality of Life 
61.11 14.6 58.33 13.9 59.72 15.3 .881 0.25 
 Physical Function 65.55 22.1 66.66 18.4 72.22 21.7 .314 0.207 
 Role Function 69.44 26.7 69.44 40.0 86.11 16.4 .413 0.162 
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Subjective Measure 
Baseline 
Post-
Treatment 
Follow-up 
Treatment p 
Effect 
Size 
M SD M SD M SD 
 Emotional Function 65.27 23.2 81.4 12.3 69.44 17.2 .112 0.355 
 Cognitive Function 47.22 24.5 72.22 13.6 72.22 8.6 .026 0.519 
 Social Function 58.33 36.1 61.11 25.1 72.22 25.1 .265 0.233 
BRIEF-A Informant Report (T-scores)
a
 
Behavioral Regulation 
Index 
56.67 7.47 50.80 6.14 57.17 8.40 .008 0.704 
 Inhibit Subscale 49.67 9.61 45.40 1.34 51.33 5.61 .164 0.363 
 Shift Subscale 56.50 13.13 54.20 15.21 59.17 12.70 .051 0.525 
 Emotional Control 
Subscale 
62.67 6.31 52.00 7.11 59.17 11.16 < .001 0.866 
 Self-Monitor Subscale 48.33 6.98 48.40 4.72 53.33 6.53 .383 0.213 
Metacognition Index 56.83 9.26 51.60 9.58 55.50 9.81 .046 0.538 
  Initiate Subscale 56.50 10.25 51.80 8.20 55.17 9.83 .194 0.336 
  Working Memory 
Subscale 
60.17 15.55 52.60 10.62 60.33 11.18 .551 0.135 
  Plan/Organize 
Subscale 
59.50 11.50 51.60 8.96 55.33 9.59  < .001 0.834 
  Task Monitor Subscale 53.50 5.99 53.20 10.01 53.17 7.81 .742 0.072 
  Organization of 
Materials Subscale 
49.83 10.74 47.00 8.92 50.00 8.17 .703 0.084 
Global Executive 
Composite 
57.00 8.46 51.20 7.16 56.50 8.83 .008 0.701 
Caregiver Quality of Life Questionnaire – Cancer (raw scores) 
Burden 15.5 4.3 10.60 6.2 15.00 6.7 .416 0.197 
Disruptiveness Scale 7.17 2.8 5.40 4.8 4.83 5.5 .671 0.095 
Positive Adaptation 10.83 2.8 10.60 4.8 10.83 5.0 .859 0.037 
Financial  2.50 2.3 1.60 1.8 2.00 2.4 .305 0.257 
Total 48.33 9.5 39.20 11.7 45.17 18.4 .369 0.205 
Note. BAI = Beck Anxiety Inventory; BDI-II = Beck Depression Inventory-II; BSI-18 – 
Brief Symptom Inventory-18; BRIEF- The Behavior Rating Inventory of Executive 
Function – Adult Version; EORTC - European Organization for Research and Treatment 
of Cancer-Core Quality of Life Questionnaire 
 
a 
Reversed scored so that for all variables higher means indicate better performance   
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Chapter 5: Discussion and Conclusions 
The literature is burgeoning with studies that have primarily focused on 
identifying CRCI and its impact on quality of life of the affected individual.  While 
limited, research has begun to focus on the management of CRCI and the identification of 
appropriate interventions to alleviate symptoms and improve quality of life in individuals 
with cancer (Von Ah, Storey, Jansen, & Allen, 2014).  A 10-week, face-to-face cognitive 
rehabilitation program (CRP) was developed to support both survivors of breast cancer 
and training partners to cope with cancer-related cognitive changes.  The purpose of the 
CRP was 1) to teach, practice, and increase the use of strategies related to attention and 
executive functioning for BCSs and their training partners; and 2) to help improve 
thinking, communication skills, mood, and overall quality of life.  What made the CRP 
unique was that training partners were integrated in all sessions, their perspective on 
BCSs everyday functioning was measured, and their own quality of life was evaluated.  
The aims of this pilot study were: 1) to determine the feasibility and acceptability of a 
brief CRP to BCSs and their training partners and 2) to determine if neuropsychological 
outcomes improved and were maintained following completion of the CRP.   
 
Aim 1: Feasibility and Acceptability 
This pilot study provided useful data concerning the feasibility of our CRP.  
Feasibility was assessed in a number of ways:  ease of recruitment, retention, attendance 
rates, homework compliance, and participant satisfaction.  
Recruitment and retention.  We were able to successfully recruit six survivors 
of breast cancer and training partners to participate in a group intervention.  Few studies 
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exist to compare this CRP.  Julious (2005) recommended a minimum sample size of 12 
per group as a rule of thumb and justified this based on rationale about feasibility and 
precision around the mean and variance.  The originally proposed sample size was 10 
dyads and future studies should aim for a minimum of 10-12 dyads per group. 
Barriers to recruitment in our study included system-level (e.g. research strategy 
procedures), clinician-level (e.g. lack of time) and participant-level factors such as BCSs 
unawareness of shortcoming, misattributing cognitive impairments to fatigue or stress 
and perhaps not having an available support system.  Although we recruited 6 dyads, the 
process was not easy.  BCSs were required to have a designated training partner 
identified at the beginning of the study.  There may have been BCSs who were interested 
in this study but lacked a partner.  The requirements for a partner may have been a 
deterrent or obstacle to potential study participants.  Without a partner it could be 
perceived that they could not participate in the CRP.  This may have contributed to low 
study enrollment.  According to Standard II.43 of the Canadian Psychological 
Association Code of Ethics (Canadian Psychological Association, 2000) psychologists 
must “not place an individual, group, family, or community needing service at a serious 
disadvantage by offering them no service in order to fulfill the conditions of a research 
design, when a standard service is available”.  One needs to ethically consider avoiding 
bias to individuals who do not have a partner but would still benefit from the CRP.  We 
did not receive any inquiries from potential participants without partners, perhaps for the 
reason previously stated; participants who met the BCS inclusion criteria but lacked a 
partner would have been invited to participate in the CRP.  Several actions were taken to 
address our main recruitment challenges such as referrals from health care professions 
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and providing adequate information to the community.  Recommendations for future 
iterations of this study are provided below.  
Health care professionals were informed of the study via mass email sent to all 
staff accounts at the cancer site.  Often email is used a viable outlet for communication 
and collaboration in a work environment.  However, our email may have been 
overlooked due to communication overload when inboxes are flooded by other mass.  
Although the intention was to reach as many staff as possible, mass emailing may no 
longer be the most effective way.  Additionally, meeting invitations to oncologists to 
request referrals and provide them with the necessary contact information for enrolment 
was unsuccessful.  Several of the oncologists were on vacation or unavailable during that 
time.  Given the busy practices of oncologists, it may have been more beneficial to 
provide written information (not email) on study information and eligibility criteria.  For 
many BCSs, follow-up care is provided by primary care providers who work outside of a 
cancer centre.  Given these scenarios, recommendations would be 1) to present study 
information to health care providers in a forum where they are together (e.g. rounds, 
program meetings) and 2) to mail study information to primary care providers in the 
community.  
There were also efforts to inform community members of the study.  Support 
group facilitators were contacted through email and were asked to print and hand-out 
materials about the study.  To improve recruitment efforts for support groups and 
community organizations, we recommend delivering a brief in-person presentation 
containing information about CRCI, information about the CRP, and how participants 
can enrol in the study.  After 2 months of no enrolment, print and broadcast media was 
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used as an additional strategy to support recruitment efforts.  These efforts proved 
successful and several individuals contacted the study coordinator.  Based on the success 
of media recruitment, we would recommend finding cost-effective strategies utilizing 
media.  These could include paid radio advertisements, radio public service 
announcements, public service announcements through local newspapers, print and 
online newsletters, and use of social media (Facebook or Twitter).  
Retention and attrition are important elements of feasibility in any intervention 
study.  Despite the recruitment challenges, all the participants who enrolled completed 
the study and a subsequent return for two additional post-intervention assessments.  
Factors that were associated with retention included the duration of the sessions (2 hours 
in person with homework), the length of the intervention was brief (10 weeks), and the 
time year the CRP was offered (winter in Northern Ontario).  Retention information was 
valuable because it provided the research team with information about what was 
acceptable or unacceptable about the intervention, and if any modifications should be 
made for future studies.   
The weekly session format of the CRP was beneficial for participants because it 
allowed an opportunity for education followed by practical activities that could be 
applied in real-life contexts.  Sessions were promoted as 1.5 hours in length but in most 
cases they lasted 2 hours.  One of the participants suggested offering the CRP in the 
afternoon; however, a systematic review by Islam et al (2014) indicated that the 
prevalence of BCSs returning to work varies from 43% to 93% following completion of 
active treatment.  In addition, caregivers (training partners) are more likely employed in 
daytime jobs.  We would not change the time of day when the CRP was offered (evening 
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versus afternoon); however, we would recommend beginning earlier (i.e. 5:30 p.m. or 
6:00 p.m.) and extending to session time from 1.5 hours to 2 hours.  This would allow 
participants to better absorb the content, ask questions, and allow for more discussion. 
There was variability in responses from the BCSs in terms of the length of 
sessions.  Most of the participants felt the length of the sessions was appropriate.  
However one felt there was too much information and the number of sessions should be 
increased.  In hindsight, the teaching modules of sessions six through nine were content 
heavy and subsequently many of the practice sessions were given as homework.  Due to 
inclement weather, it was necessary to cancel one of the sessions.  Subsequently sessions 
8 and 9 were combined into one session to ensure the CRP program finished on its 
intended date.  The combined session resulted in the teaching modules that were loaded 
in content and one of the participants commented that “having the two sessions at the 
same time was too much and the homework was intense” for them.   
Although there is no evidence to support the effects of duration and intensity of 
CRPs, Cicerone et al. (2000) reported that “maintenance and generalizations of benefits 
from cognitive rehabilitation are greatest when treatment is provided for approximately 
long periods of time”.  Similar to cognitive behavioural therapy, this CRP was time-
limited.  Cognitive behavioural therapies usually have a course of weekly therapy 
sessions lasting 12-16 weeks.  Therefore if the CRP were to run again, duration of 12-16 
weeks is recommended to allow the content to be spread over more sessions. 
Attendance.  The high attendance rate for participants would support the idea that 
physically attending treatment may be therapeutic in a manner that promotes maintenance 
of gains in some patients, compared to a telephone- or internet based intervention.  Mohr 
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and colleagues (2012) postulated that attending face-to-face therapy may serve as a form 
of behavioural activation.  Another possibility that Mohr et al., (2012) suggested was that 
“the physical presence of the therapist, although not having an effect during treatment, 
contributes to the maintenance of gains, which suggests that human contact may have 
unique qualities that exert their effects and contribute to resilience after contact has 
ceased.”  Although support does not necessarily have to be provided face-to-face, the 
structure of the CRP (i.e., group based) does not permit using a videoconferencing or 
telephone based approach.  Moreover, the high attendance rates provide support that the 
structure of the CRP was important and beneficial to BCSs and training partners. 
Homework compliance.  Participants were assigned between-session homework 
that involved practice of the previous session’s content.  We thought that the use of 
between-session homework activities would likely promote the use of skills learned 
during the sessions.  Participants often reported that they completed their homework, 
suggesting that homework was acceptable.  Homework has an extensive history in the 
broader psychotherapy literature (Kazantzis Whittington & Dattillio, 2010) and is 
primarily used to help generalise skills developed in session to the participant’s broader 
world and prolong “symptom improvement by extending therapeutic aspects of treatment 
beyond the completion of therapy” (Kazantzis & Lampropoulos, 2002; Mausbach, Moore 
& Patterson, 2009).  Participants may have been inclined to report completing homework 
in a socially desirable fashion.  Participants may be exaggerating their degree of 
compliance with homework assignments.  Future iterations of the study could add a 
clinician-rated homework scale to allow for comparisons of homework compliance.  
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Program evaluation.  There were several benefits to offering a group-based 
intervention in addition to cost-effectiveness: 1) a group format can also reduce an 
individual’s sense of alienation by allowing them to feel part of a cohesive group of 
participants (Yalom, 2005) and; 2) the group-based intervention created a forum for 
educational sessions and the exchange of ideas regarding coping strategies and 
compensatory techniques.  Positive feedback indicated that survivors of breast cancer 
found the intervention helpful in dealing more effectively with their difficulties.  Training 
partners were similarly enthusiastic about the intervention strategies and rated instructors 
for the caregiver group sessions as well-prepared and helpful.  Furthermore, participants 
often remarked that there was an increased, positive ability to cope with CRCI issues, and 
that the discussion of issues and coping strategies were important to them.  Mateer and 
Sohlberg (2001) stated that rehabilitation success depends on a true collaboration with the 
client and family members in the client’s life.  Upon completion of the study, all the 
BCSs felt they were more informed about the cognitive changes they experienced 
following chemotherapy, and four of them felt they were much improved compared to 
their feeling prior to beginning this study.  Overall, all the participants were satisfied with 
the CRP and indicated that they would recommend the intervention to others if offered 
again. 
 
Aim 2: Improvement and Maintenance of Neuropsychological Outcome Measures 
The participants tolerated the three-hour test battery of neuropsychological 
measures during all assessment sessions.  The test battery was deemed suitable for use as 
a comprehensive assessment that could be repeated with minimal practice effects 
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(alternate forms were used where available) and minimal patient fatigue.  The addition of 
a control group could possibly clarify any practice effects and the differences observed in 
the CRP group.  Despite their common use, cognitive screeners such as the Mini-Mental 
State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are not 
sensitive enough to detect the presence and breath of subtle cognitive impairment 
commonly seen in individuals breast cancer (Baschnagel, Wolters, & Camphausen, 2008; 
Root, Ryan, & Ahles, 2015; Lange et al., 2014).  On the opposite side of the spectrum, 
traditional neuropsychological batteries such as the Halstead-Reitan Neuropsychological 
Battery, Luria-Nebraska (Lezak et al., 2004) are generally time-consuming to administer 
in a research setting – they can take up to 8-10 hours to administer.  The compromise is 
having a brief test battery that is reliable and sensitive to detect meaningful 
neuropsychological change.  The study’s test battery not only proved suitable in a 
research setting, but, given the breath of cognitive areas it covers, it would likely be 
useful to evaluate cognitive changes and predict outcome in a clinical setting.  
Hypothesis I sought to evaluate the effects of the CRP through analyzing baseline 
measures versus the post-intervention assessment.  At baseline, the mean test scores from 
the BCS group were within normal limits for all measures.  This data is consistent with 
results reported by Reid-Arndt, Hsieh, and Perry (2010) that cognitive abilities are within 
normal limits for a majority of breast cancer survivors in the year following active 
treatment.  On self-report measures, BCSs reported mild anxiety, mild depression, low 
levels of psychological distress and low levels of impairments on executive function 
behaviour in their everyday environment.   
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The results of the current study revealed few significant findings in support of the 
hypothesized relationship between short term cognitive rehabilitation and measurable 
improvements in neuropsychological measures.  Repeated measures ANOVAs did not 
demonstrate significant effects for time on most measures.  Significant main effects and 
moderate effect sizes for time were noted on measures of attentional capacity, 
impulsivity, detectability, motor dexterity and grip strength of the non-dominant hand, 
confrontation naming, and visuospatial perception.  Additionally, statistical evidence in 
this pilot study does not provide solid evidence of supporting the original pilot hypothesis 
that a CRP is efficacious in improving and/or maintaining cognitive impairments 
following a brief CRP.  
Hypothesis II evaluated whether the CRP resulted in sustained improvements 
over time on neuropsychological measures.  Similar to hypothesis I, repeated measures 
ANOVAs did not demonstrate significant effects for time on most measures.  A main 
effect for time was demonstrated on a measure of detectability (CPT-2: d’), suggesting 
that BCSs improved their ability to distinguish relevant from irrelevant information.  This 
ability is related to the concepts of executive control and inhibition.  According to 
Fernandez-Duque, Baird and Posner (2000), this type of executive functioning relates to 
better metacognitive monitoring, which involves control processes such as conflict 
resolution and emotional regulation.  At the very least, these result suggest that the BCSs 
may have utilized the strategies taught from the CRP and developed the confidence to 
attempt to use them.   
Hypothesis III sought to evaluate if the CRP resulted in observable gains in the 
performance of activities of daily living.  Specifically, results of this pilot study indicate 
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that the CRP is associated with improvements in self-reported subjective cognition, 
psychosocial distress, social functioning, and fatigue.  Differences of at least 10 points 
(on a 0-100 scale), are classified as the minimum clinically meaningful change in a health 
related quality of life parameter (Osoba, Rodrigues, Myles, Zee & Pater, 1998).  
Comparing baseline to 20-weeks after completion of the program, large improvements 
(greater than 20 points change) were reported on the following functional and symptom 
scales of the EORTC QLQ-C30:  Role (the ability to work or participate in leisure 
activities);  Cognitive (the ability to concentrate or remember things);  Social (physical 
conditions or medical treatments interfering with family life or social activities);  Fatigue 
(the need for rest, feeling of weakness or tiredness) and future perspectives (worries 
about health in feature.  The large change in these scales suggests that the content, 
activities, and discussions that occurred during the CRP provided an important 
framework for the participants’ self-awareness.  Low scores over time on the Perceived 
Deficits Questionnaire indicated that the BCSs perceived fewer deficits both immediately 
after the intervention and at 20-week follow-up.  Program evaluation and subjective 
measures indicated the participants felt better.  This suggests that the CRP has some 
beneficial influence on mood and on quality of life. 
Additionally, the pilot study was not able to tease out the relative effectiveness of 
cognitive retraining versus the use of compensatory strategies.  Given the small sample 
size, it is reasonable to take note of data trends that could become statistically significant, 
in a study with a greater sample size.  For example, trends were found in a review of 
neuropsychological measures of sustained attention, measures of executive functioning, 
semantic and phonemic fluency, verbal learning and delayed recall.  Self-report measures 
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demonstrated trends in the areas of psychological health status (BSI-18), declines in self-
reported depressive symptoms, (BDI-II), declines in anxious symptoms (BAI), and 
improvements in perceived difficulties with organization, concentration, and memory 
(PDQ).  Although the above data are trending in a positive direction (from the 
perspective of intervention effectiveness) these changes remain marginal and to some 
degree uncertain because of the small sample size.  The trends towards improvement on 
objective and self-report measures could be considered as an indirect cue of the 
importance of direct and compensatory training in everyday life.  Furthermore, mean 
scores fell within the normative range across measures and across time.  This finding 
conceals the heterogeneity in recovery outcomes and underscores the limitations of 
examining only group data with a small sample size.   
Cicerone et al., (2000) emphasized that regardless of the specific approach or area 
of intervention, cognitive rehabilitation should be directed at promoting changes that 
improve functioning in areas of relevance to an individual‘s everyday life.  There is 
evidence to indicate that the effect sizes from cognitive rehabilitation are largest when the 
training closely resembles outcomes measures, suggesting task-specific or skill-specific 
effects.   Despite moderate to large effect sizes on many of the objective and subjective 
measures, given the small sample size many of the comparisons failed to reach 
significance.  On objective measures that were statistically significant, large effect sizes 
for changes across time were observed in the areas of attentional capacity (pƞ
2  
= .59), 
inattentiveness (pƞ
2  
= .45), detectability (pƞ
2  
= .59), non-dominant grip strength (pƞ
2  
= .59), non-dominant manual dexterity (pƞ
2  
= .65),  confrontation naming (pƞ
2  
= .65), and 
visuospatial perception (pƞ
2  
= .50).  Moderate effect sizes for changes across time were 
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also observed on self-reported measures of generalized anxiety (pƞ
2  
= .53), an index score 
on the ability to cognitively self-manage tasks and to monitor performance (pƞ
2  
= .49), 
perceived retrospective memory dysfunction (pƞ
2  
= .48), perceived prospective memory 
dysfunction (pƞ
2  
= .51), and subjective cognitive functioning (pƞ
2  
= .52).  The preliminary 
data indicated that improvements were observed in the rehabilitated neuropsychological 
domains and may provide a focal point to optimize the design of subsequent studies.   
Reliable change indices (RCIs) were calculated to assess if there were changes at 
the individual level that would be clinically meaningful.  RCIs did not confirm if the CRP 
induced improvement at the individual level on most measures.  The test-retest reliability 
and SD for each objective measure were derived from published data.  Perhaps the lack 
of change can be attributed to the difficulty in finding normative data for the breast 
cancer population or having a local control group. 
Caregivers.  In addition, caregivers of individuals with cancer can be faced with 
substantial challenges.  An illness, such as breast cancer, can cause a major disruption in 
lives of individuals and their families.  Aspects of this disruption, in turn, can impact the 
behaviours, roles, and responsibilities held by the individual with breast cancer and their 
partner in the family unit (Northouse, 1989; Northouse, Katapodi, Song, Zhang, & Wood, 
2010).  Caregivers may be faced with role adjustments that can culminate in problems 
managing responsibilities at work, home and in other family relationships (Girgis, 
Lambert, Johnson, Waller & Currow, 2013).  Perceived quality of life for the training 
partners was evaluated using the Caregiver Quality of Life Index-Cancer (CQOLC) 
questionnaire.  The training partners rated their mental/emotional burden, lifestyle 
disruption, financial concerns, hopefulness as low.  The scores remained relatively stable 
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across assessments suggesting low caregiver burden in our training partners.  Although 
this is a pilot study, the results highlight the importance of enlisting caregivers to help 
incorporate cognitive strategies and exercises into the survivor’s everyday life.  There 
also seems to be a direct benefit to the training partner in terms of reduced caregiver 
burden and improved quality of life.  Despite the positive findings, the results are limited 
to a pilot study design and cannot be generalized to all populations.  Further evaluation is 
warranted in order to help rule out confounds such as training partner demographics.  
 
Limitations  
The pilot study had several limitations.  The small sample size may limit the 
interpretability of the results.  The sample size was far too small to address potentially 
confounding factors such as chemotherapy treatments, concurrent medication use, and 
fatigue.  Similar to other studies, the sample of BCSs was heterogeneous in terms of 
disease, treatment and demographics, and therefore, the effects of these variables on 
intervention efficacy could not be addressed due to the lack of statistical power.  It is 
known that comparison of uneven group sizes is not methodologically ideal (Meyers, 
Gamst, Guarino, 2006).  To address the issues of small and uneven group numbers and 
lack of a control comparison group, interpretation of results incorporated effect sizes that 
are independent of group size.  Reliable change indices used information available from 
general population studies and did not have a control group for which to compare 
changes.  Participants served as their own controls.  Unpublished data (Mariani, 2014) 
indicated that the baseline premorbid full-scale IQ was nearly the same for participants in 
this pilot study compared to local BCSs.  The baseline cognitive profile indicated that the 
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participants in the CRP had lower mean T-scores in visual and verbal memory and 
executive function compared to the local sample.   
There was a relatively large number of neuropsychological and subjective 
measures.  The test battery was comprehensive and administration time was 
approximately 2-3 hours.  This comprehensive test battery and time were necessary given 
the complex nature of the phenomena under investigation.  Further studies may want to 
reduce the number of neuropsychological tests within the battery used and select tests 
that are initially known to be sensitive and specific to detect changes in CRCI.  An 
assessment should have a comprehensive battery that is sensitive and specific to detect 
minimal impairments and include the areas known to be involved with CRCI.  Analysing 
cognitive domains (domain specific) and an overall impairment (global deficit) could be 
used as an approach  to focus on the most reliable and salient measures and to reduce the 
number of statistical tests performed in this relatively small sample.  However, ICCTF 
(Wefel et al., 2011) recommends against this approach to longitudinally monitor changes 
in cognitive function since declines from a higher level to the average range would be 
ignored. 
Another potential criticism of this study was the use of self-reports to gather data.  
Self-report questionnaires are widely used as proxy measures of clinical outcomes.  
Unfortunately, bias associated with self-report questionnaires is quite common and can 
potentially influence the outcome of the targeted construct.  An advantage of self-
reporting is that it gives the researcher, the respondents’ own perspective.  The 
disadvantage is that there are potential validity problems such as truthfulness or 
deception.  Patient reported outcomes are a necessity for research, thus it is paramount 
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that researchers and clinicians utilize effective methods for controlling bias in a study.  
Although data collection was not blind in this study, self-report measures were written to 
deter the possibility of interviewer bias (Tourangeau & Smith, 1996).  
There were challenges with the development of the CRP (manual and content).  
The manual was not completed in its entirety prior to the start of the first session and 
posed a weekly challenge to complete session content.  Each weekly session was 
completed a few hours or 1 day prior to delivery.  Rarely do interventions run exactly as 
it is written in the manual, and facilitation can be unpredictable. Several of the session 
activities and homework used audio and sound quality proved suboptimal.  The attention-
based activities were read by one of the facilitators and the participants indicated there 
was difficulty in listening (i.e. rate of speech was too fast and speaker would pause 
abruptly).  In addition, several of the handouts had grammatical errors.  Regardless of 
these procedural issues, participants did rate the facilitators as well-prepared.  This 
preparedness can be attributed to the facilitator’s years of experience in group facilitation, 
and working with individuals diagnosed with cancer and their families.  Given this is the 
first time the pilot study occurred, the CRP manual was completed in draft format 
simultaneously while running the program.  
Finally, the study results can only be generalized to BCSs in Northern Ontario 
who report having cognitive symptoms and score(s) below a predetermined cut-off on 
objective neuropsychological tests.  Results may not apply to survivors who have 
significant cognitive impairment on the basis of objective test results.  Subsequently, 
results may apply only to survivors with relatively mild deficits, similar to the group 
studied, who have sufficient cognitive resources and motivation to follow the 
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rehabilitation program and report cognitive symptoms.  Similar to most studies with 
BCSs, the inherent heterogeneity of this sample in terms of disease and treatment factors 
may limit the generalizability of these results to other cancer populations.  These factors 
will need to be addressed in further, larger studies. Nonetheless, this was a pilot study and 
to our knowledge, the first study to implement a concurrent cognitive rehabilitation 
approach with BCS and training partners. 
 
Conclusion 
CRPs are increasingly recognized as beneficial alternatives and/or as adjunctive 
therapy to medications for improving specific types of cognitive dysfunction in 
individuals with neurological disorders or maintaining individuals at their current level.  
There is limited evidence for the effectiveness of cognitive rehabilitation in BCSs.  The 
cognitive training programs for traumatic brain injury and Alzheimer’s disease that 
utilize the well-developed programs have shown a number of improvements.  
Improvements occur in memory, attention, executive functioning, and problem solving 
(Cicerone et al., 2005).  The improvements demonstrated the feasibility of these 
retraining programs.  Despite the increasing concern regarding cognitive changes 
associated with CRCI, few studies have been designed and conducted to evaluate 
interventions to treat cognitive changes.  If cognitive impairment is detected or reported 
by survivors of breast cancer, strategies to help them and their family members cope with 
these changes may be useful.  The results of the study contribute to the literature on 
cognitive rehabilitation for the cancer population. 
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Irrespective of the shortcomings, the BCSs reported subjective improvement in 
cognition, mood and quality of life, and training partners reported reduced burden.  All 
participants reported improved communication, were satisfied with the program, and 
indicated that they would participate in the program again and recommend it to a friend.  
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